Apr 30, 08
|
| NEW STORY |
| 15:00 ET |
Bristol-Myers Squibb Invites Public to Listen to Webcast of 2008 Annual Meeting
|
|
Apr 29, 08
|
| NEW STORY |
| 08:30 ET |
Bristol-Myers Squibb Issues $1.6 Billion of Senior Notes
|
|
Apr 26, 08
|
| 12:00 ET |
BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
|
|
Apr 24, 08
|
| 07:30 ET |
Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company
|
|
Apr 17, 08
|
| 12:00 ET |
Bristol-Myers Squibb to Announce Results for the First Quarter of 2008 on April 24
|
|
Apr 08, 08
|
| 15:15 ET |
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
|
|
Mar 24, 08
|
| 16:09 ET |
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
|
|
Mar 17, 08
|
| 09:00 ET |
Bristol-Myers Squibb to Present at Healthcare Conferences
|
|
Mar 05, 08
|
| 07:15 ET |
Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
|
|
Mar 04, 08
|
| 16:30 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Feb 29, 08
|
| 08:30 ET |
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
|
|
Feb 27, 08
|
| 21:15 ET |
Great Comebacks(R) Program Announces 2007 National Award Winner
|
 |
Feb 12, 08
|
| 10:12 ET |
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
|
|
Feb 06, 08
|
| 18:05 ET |
CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
|
|
Jan 31, 08
|
| 07:30 ET |
Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
|
|
Jan 22, 08
|
| 12:19 ET |
Bristol-Myers Squibb Names Togo D. West, Jr. to Board of Directors
|
|
Jan 16, 08
|
| 12:00 ET |
Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
|
|
Dec 17, 07
|
| 13:30 ET |
European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
|
|
| 08:30 ET |
Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb Medical Imaging for Approximately $525 Million
|
|
Dec 11, 07
|
| 08:00 ET |
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
|
|
Dec 10, 07
|
| 16:26 ET |
Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
|
|
Dec 05, 07
|
| 12:00 ET |
Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
|
|
Dec 04, 07
|
| 16:05 ET |
Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
|
|
Nov 30, 07
|
| 13:00 ET |
Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
|
|
Nov 28, 07
|
| 10:30 ET |
Bristol-Myers Squibb to Webcast December 5 Business Update
|
|
Nov 27, 07
|
| 09:30 ET |
World Aids Day Campaign to Shine a Light of Hope on the HIV/AIDS Epidemic in the United States
|
|
Nov 23, 07
|
| 07:00 ET |
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
|
|
Nov 20, 07
|
| 11:01 ET |
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
|
|
Nov 19, 07
|
| 18:51 ET |
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
|
|
Nov 15, 07
|
| 10:00 ET |
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
|
|
Nov 14, 07
|
| 17:00 ET |
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
|
|
Nov 12, 07
|
| 12:55 ET |
Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
|
|
Nov 09, 07
|
| 08:06 ET |
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
|
|
Nov 02, 07
|
| 09:00 ET |
Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels
|
|
Oct 25, 07
|
| 07:30 ET |
Bristol-Myers Squibb Company Reports Financial Results for the Third Quarter and First Nine Months of 2007
|
|
Oct 17, 07
|
| 08:00 ET |
Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
|
|
| 05:00 ET |
ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
|
|
Oct 16, 07
|
| 17:00 ET |
FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
|
|
Oct 08, 07
|
| 10:00 ET |
Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
|
|
Oct 02, 07
|
| 20:17 ET |
Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
|
|
Sep 28, 07
|
| 13:04 ET |
Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
|
|
Sep 27, 07
|
| 13:00 ET |
Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
|
|
| 09:00 ET |
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
|
|
Sep 24, 07
|
| 09:01 ET |
Bristol-Myers Squibb to Acquire Adnexus Therapeutics
|
|
Sep 18, 07
|
| 10:13 ET |
New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
|
|
Sep 13, 07
|
| 08:00 ET |
Screen and Stage Legend Phylicia Rashad Launches a Campaign Close to Her Heart
|
|
Sep 11, 07
|
| 16:48 ET |
Bristol-Myers Squibb Announces Dividend
|
|
| 01:46 ET |
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
|
|
Sep 10, 07
|
| 09:12 ET |
Bristol-Myers Squibb to Present at Bear Stearns Healthcare Conference, Reaffirms Financial Guidance
|
|
Aug 27, 07
|
| 07:30 ET |
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
|
|
Aug 15, 07
|
| 09:00 ET |
ConvaTec Launches Moldable Technology(TM), Custom-Fitting Skin Barriers
|
|
Jul 27, 07
|
| 16:45 ET |
Bristol-Myers Squibb and ImClone Systems Significantly Expand ERBITUX Clinical Development Program
|
|
Jul 26, 07
|
| 07:00 ET |
Bristol-Myers Squibb Company Reports Financial Results for the Second Quarter and First Half of 2007
|
|
Jul 23, 07
|
| 00:15 ET |
Bristol-Myers Squibb's SECURE THE FUTURE(R) Program Offers New Approach to Replicate Successful HIV Treatment Support Model
|
|
Jul 12, 07
|
| 07:00 ET |
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
|
|
Jul 09, 07
|
| 10:00 ET |
Bristol-Myers Squibb to Announce Results for the Second Quarter of 2007 on July 26
|
|
Jul 06, 07
|
| 05:00 ET |
Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
|
|
Jun 29, 07
|
| 07:30 ET |
Bristol-Myers Squibb Signs Agreement for Sale of Bufferin(R) and Excedrin(R) to Lion Corporation in Japan, Asia and Oceania
|
|
Jun 25, 07
|
| 16:45 ET |
Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
|
|
| 10:06 ET |
First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
|
|
Jun 19, 07
|
| 07:00 ET |
FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone
|
|
Jun 15, 07
|
| 08:09 ET |
Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia(R) (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
|
|
Jun 14, 07
|
| 16:16 ET |
Statement on the Deferred Prosecution Agreement Following Press Release From U.S. Attorney
|
|
Jun 12, 07
|
| 16:10 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Jun 11, 07
|
| 07:00 ET |
FDA Accepts and Grants Priority Review of Erbitux(R) (Cetuximab) sBLA for Overall Survival in Patients With Advanced Colorectal Cancer
|
|
Jun 05, 07
|
| 08:00 ET |
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for Pediatric Patients With Schizophrenia Accepted for Priority Review by the U.S. Food and Drug Administration
|
|
Jun 03, 07
|
| 10:00 ET |
Phase III Ixabepilone Study Demonstrated Significant Improvement in Progression-Free Survival in Patients With Advanced Metastatic Breast Cancer
|
|
May 10, 07
|
| 16:41 ET |
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
|
|
May 09, 07
|
| 07:00 ET |
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals
|
|
May 07, 07
|
| 12:00 ET |
'AIM for the B' Public Education Program To Raise Awareness of Chronic Hepatitis B Among Communities Most Affected by the Disease
|
|
Apr 26, 07
|
| 07:30 ET |
Bristol-Myers Squibb Company Reports First Quarter 2007 Financial Results
|
|
| 07:30 ET |
James M. Cornelius Elected Bristol-Myers Squibb CEO
|
|
| 07:00 ET |
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
|
|
Apr 16, 07
|
| 11:00 ET |
Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning Photographs in Contest Communicating Personal Experiences with HIV/AIDS Through Photography
|
|
Apr 13, 07
|
| 08:10 ET |
BARACLUDE(R) (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment
|
|
Apr 04, 07
|
| 02:00 ET |
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
|
|
Mar 06, 07
|
| 17:05 ET |
Bristol-Myers Squibb Announces Dividend
|
|
| 15:45 ET |
Bristol-Myers Squibb Names Michael Grobstein to Board of Directors
|
|
Feb 16, 07
|
| 16:29 ET |
Bristol-Myers Squibb Completes Land Acquisition for New Biologics Facility
|
|
Feb 15, 07
|
| 13:00 ET |
Bristol-Myers Squibb Names Sandra Leung Senior Vice President and General Counsel
|
|
Feb 05, 07
|
| 02:00 ET |
ImClone Systems Incorporated and Bristol-Myers Squibb Announce Application In Japan for Use of ERBITUX in Metastatic Colorectal Cancer
|
|
Jan 17, 07
|
| 10:00 ET |
Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2006 on January 25
|
|
Jan 11, 07
|
| 07:00 ET |
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
|
|
Jan 10, 07
|
| 02:00 ET |
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
|
|
Dec 28, 06
|
| 13:38 ET |
Canadian Federal Court of Appeals Rules in sanofi-aventis' Favor in the Canadian Plavix Notice of Compliance Proceedings
|
|
Dec 27, 06
|
| 00:01 ET |
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan
|
|
Dec 21, 06
|
| 08:00 ET |
Bristol-Myers Squibb Announces Agreement In Principle to Settle Federal Investigation Into Pricing, Sales And Marketing Practices
|
|
Dec 18, 06
|
| 07:00 ET |
Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to Discover and Develop Novel Oncology Compounds
|
|
Dec 13, 06
|
| 10:00 ET |
Bristol-Myers Squibb to Hold Investor Teleconference to Discuss Data Presented at ASH Meeting
|
|
Dec 12, 06
|
| 08:00 ET |
ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available
|
|
Dec 11, 06
|
| 08:30 ET |
STUDY OF SPRYCEL(R) (DASATINIB) OR 800 MG OF GLEEVEC(R)* (IMATINIB MESYLATE) SHOWS PATIENTS TREATED WITH SPRYCEL ACHIEVED HIGH CYTOGENETIC RESPONSES AND PROLONGED PROGRESSION-FREE SURVIVAL
|
|
| 08:19 ET |
STUDY SHOWS SPRYCEL(R) (DASATINIB) 100 MG ONCE A DAY PROVIDES RESPONSES SIMILAR TO THOSE IN PATIENTS TAKING APPROVED 70 MG TWICE A DAY DOSE, WITH REDUCED INCIDENCE OF SIDE EFFECTS
|
|
Dec 08, 06
|
| 13:27 ET |
Preliminary Injunction Against Apotex Upheld on Appeal
|
|
Dec 05, 06
|
| 16:05 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Dec 01, 06
|
| 07:30 ET |
Bristol-Myers Squibb Company Announces Voluntary Delisting From NYSE Arca
|
|
Nov 27, 06
|
| 14:10 ET |
Bristol-Myers Squibb and The National AIDS Fund Announce World AIDS Day Campaign to Shine a Light on the HIV/AIDS Epidemic in the United States
|
|
Nov 20, 06
|
| 12:23 ET |
Crohn's and Colitis Foundation of America and ConvaTec Recognize Young Patients With Inflammatory Bowel Disease
|
|
| 07:45 ET |
Bristol-Myers Squibb Announces Results of the Tender Offer for Its 5.75% Notes Due October 1, 2011
|
|
Nov 17, 06
|
| 10:02 ET |
Catholic Medical Mission Board Announces Donation of Lifesaving Pediatric Drugs
|
|
Nov 16, 06
|
| 18:42 ET |
Bristol-Myers Squibb Prices Tender Offer on its 5.75% Notes Due October 1, 2011
|
|
Nov 14, 06
|
| 18:19 ET |
Bristol-Myers Squibb Company Announces Promotion of Andrew Bonfield and Elliott Sigal to Executive Vice Presidents
|
|
| 17:10 ET |
ORENCIA(R) (abatacept) or REMICADE(R)(infliximab) Demonstrated Superior Efficacy to Placebo at Six Months With ORENCIA Demonstrating Both Durable Efficacy and a More Favorable Safety Profile Through 12 Months
|
|
Nov 13, 06
|
| 15:27 ET |
ORENCIA(R) (abatacept) Data Demonstrated Improvement in Children and Adolescents With Juvenile Idiopathic Arthritis as Measured by the Validated ACR Pediatric Criteria
|
|
Nov 09, 06
|
| 02:30 ET |
Bristol-Myers Squibb Company Announces Debt Tender Offer
|
|
Nov 06, 06
|
| 05:00 ET |
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
|
|
Oct 30, 06
|
| 15:15 ET |
Three-Year Data Showed Low Incidence of BARACLUDE(R) (Entecavir) Resistance in Nucleoside-Naive Chronic Hepatitis B Patients
|
|
| 15:00 ET |
BARACLUDE(R) (Entecavir) Demonstrated Viral Suppression to Undetectable Levels in Most Patients in a Three-Year Cohort
|
|
| 08:00 ET |
Study Shows Treatment with BARACLUDE(R) (Entecavir) Resulted in Greater Viral Load Reductions Compared to Adefovir in Antiviral Naive Chronic Hepatitis B E-Antigen Positive Patients
|
|
Oct 26, 06
|
| 07:31 ET |
Bristol-Myers Squibb Company Reports Financial Results for the Third Quarter and First Nine Months of 2006
|
|
Oct 16, 06
|
| 11:05 ET |
Bristol-Myers Squibb to Announce Results for the Third Quarter of 2006 on October 26
|
|
Oct 09, 06
|
| 02:30 ET |
Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) to European Medicines Agency
|
|
Sep 21, 06
|
| 17:29 ET |
Plavix(R) Preliminary Injunction Appeal
|
|
Sep 13, 06
|
| 02:30 ET |
Bristol-Myers Squibb Company and Medivir AB Announce Worldwide Collaboration to Develop and Commercialize MIV-170 for the Treatment of HIV-1 Infection in Adults
|
|
Sep 12, 06
|
| 14:28 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Sep 11, 06
|
| 17:26 ET |
Bristol-Myers Squibb Board of Directors Establish Science and Technology Committee of the Board
|
|
| 17:24 ET |
Bristol-Myers Squibb Names R. Sanders Williams, M.D. to Board of Directors
|
|
Sep 01, 06
|
| 19:33 ET |
Bristol-Myers Squibb Lowers 2006 Earnings Per Share Guidance
|
|
Aug 17, 06
|
| 09:56 ET |
Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY(R) DISCMELT(TM) (aripiprazole)
|
|
Aug 14, 06
|
| 13:45 ET |
Motion Filed for Preliminary Injunction in PLAVIX(R) Patent Infringement Case
|
|
Aug 13, 06
|
| 11:30 ET |
Clinical Results Show Integrating Medical Care With Community Supports Is Key to Successful Outcomes for HIV Patients in Resource-Limited Settings
|
|
Jul 28, 06
|
| 20:00 ET |
PLAVIX(R) Litigation Settlement Fails to Receive Antitrust Clearance From States Attorneys General
|
|
Jul 27, 06
|
| 08:17 ET |
Bristol-Myers Squibb Company Reports Financial Results for the Second Quarter and First Half of 2006
|
|
Jul 18, 06
|
| 08:45 ET |
Bristol-Myers Squibb to Announce Results for the Second Quarter of 2006 on July 27
|
|
Jul 11, 06
|
| 16:46 ET |
Bristol-Myers Squibb Names Vicki L. Sato to Board of Directors
|
|
Jun 28, 06
|
| 16:58 ET |
FDA Approves SPRYCEL(TM) (dasatinib) With Two Indications
|
|
Jun 25, 06
|
| 11:00 ET |
Update on Plavix(R) Litigation Settlement
|
|
Jun 23, 06
|
| 09:00 ET |
New Two-Year ORENCIA(R) (abatacept) AIM Data Presented at Annual EULAR Congress
|
|
Jun 14, 06
|
| 17:15 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Jun 03, 06
|
| 16:00 ET |
Data From a Randomized Phase II Study of Dasatinib or 800 Mg/Day Imatinib- Mesylate (Gleevec(R)) Presented at the 42nd Annual Meeting of the American Society of Clinical Oncology
|
|
Jun 02, 06
|
| 14:57 ET |
Bristol-Myers Squibb Issues Statement on Oncologic Drugs Advisory Committee Vote in Favor of Investigational Drug Dasatinib
|
|
May 31, 06
|
| 11:00 ET |
Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
|
|
May 25, 06
|
| 14:03 ET |
Six-Month Study Evaluated Effectiveness of Aripiprazole and Standard of Care In Management of Community-Treated Patients with Schizophrenia
|
|
May 23, 06
|
| 11:45 ET |
96-Week Viral Suppression Data From Two Studies Presented for BARACLUDE(R) (entecavir) in Chronically-Infected Hepatitis B Patients
|
|
May 16, 06
|
| 09:00 ET |
ABILIFY(R) (Aripiprazole) Demonstrated Efficacy as Maintenance Therapy In Adults with Bipolar I Disorder Following Treatment for a Recent Manic or Mixed Episode
|
|
May 05, 06
|
| 16:41 ET |
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) Supplemental Biologics License Application (sBLA) for Third-Party Manufacturing Facility Lonza Biologics Inc.
|
|
Apr 27, 06
|
| 07:30 ET |
Bristol-Myers Squibb Company Reports First Quarter 2006 Financial Results
|
|
Apr 17, 06
|
| 13:00 ET |
Bristol-Myers Squibb Company Names David I. Johnson President of ConvaTec
|
|
| 08:30 ET |
Bristol-Myers Squibb to Announce Results For The First Quarter of 2006 on April 27
|
|
Mar 21, 06
|
| 16:30 ET |
Sanofi-aventis and Bristol-Myers Squibb Announce Agreement to Settle U.S. PLAVIX(R) Litigation with Apotex Subject to Certain Conditions
|
|
Mar 08, 06
|
| 17:01 ET |
The New England Journal of Medicine Reports BARACLUDE(TM) (entecavir) Demonstrated Benefits Over Lamivudine In Treating Chronically Infected Hepatitis B Patients at 48 Weeks
|
|
| 08:02 ET |
Bristol-Myers Squibb Plans to Build Biologics Facility in the U.S.
|
|
Mar 07, 06
|
| 16:01 ET |
Bristol-Myers Squibb Announces Dividend
|
|
| 08:01 ET |
FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Dasatinib
|
|
Mar 01, 06
|
| 19:29 ET |
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck Cancer
|
|
Feb 28, 06
|
| 07:54 ET |
U.S. Food and Drug Administration Approves EMSAM(R) (selegiline transdermal system), the First Transdermal Patch for the Treatment of Major Depressive Disorder
|
|
Feb 24, 06
|
| 04:00 ET |
Swaziland's First Children's HIV/AIDS Medical Center Opens; Building Treatment Capacity in the World's Hardest Hit Country
|
|
Feb 21, 06
|
| 09:20 ET |
Mead Johnson Recalls One Batch of Gentlease(TM) Powder Infant Formula in 24 Ounce Cans
|
|
Feb 09, 06
|
| 13:00 ET |
New 48 Week Clinical Trial Data Reported Comparing REYATAZ(R) (Atazanavir Sulfate), With or Without Ritonavir, in Treatment-Naive Patients
|
|
| 08:30 ET |
Bristol-Myers Squibb Announces Preliminary Approval of Settlement in Shareholder Class Action Litigation
|
|
Jan 25, 06
|
| 06:59 ET |
Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2005 and Announces EPS Guidance for 2006
|
|
Jan 23, 06
|
| 07:00 ET |
Bristol-Myers Squibb Announces Litigation Reserve
|
|
Jan 18, 06
|
| 11:04 ET |
Bristol-Myers Squibb to Announce Results for the Fourth Quarter and 12 Months of 2005 on January 25
|
|
Jan 03, 06
|
| 16:00 ET |
Study Reported in JAMA Concludes That High Level of Hepatitis B Virus in Patients With Chronic Hepatitis B Infection Predicts Increased Risk For Liver Cancer
|
|
Dec 28, 05
|
| 15:45 ET |
Bristol-Myers Squibb Submits New Drug Application for Dasatinib
|
|
Dec 22, 05
|
| 08:04 ET |
Bristol-Myers Squibb Statement on Muraglitazar, an Investigational Oral Treatment for Type 2 Diabetes
|
|
Dec 20, 05
|
| 08:04 ET |
Crohn's Patient Robert Hill to Scale Antarctic Summit for Intestinal Disease Awareness
|
|
Dec 16, 05
|
| 10:00 ET |
More Than 100,000 People Unite to Support AIDS Prevention and Care Programs Through Bristol-Myers Squibb 2005 World AIDS Day Campaign
|
|
Dec 12, 05
|
| 13:00 ET |
Bristol-Myers Squibb Updates the Investment Community on the Continued Execution of the Company's Strategy
|
|
Dec 06, 05
|
| 17:00 ET |
Bristol Myers Squibb Company Announces Dividend
|
|
Dec 05, 05
|
| 13:00 ET |
Bristol-Myers Squibb Company to Webcast December 12 Business Update
|
|
Dec 02, 05
|
| 14:29 ET |
Bristol-Myers Squibb Promotes John E. Celentano to President of Health Care Group
|
|
Dec 01, 05
|
| 01:00 ET |
First Children's HIV/AIDS Medical Center Opens in Lesotho; Public-Private Partnership Provides Staffing, Funding
|
|
Nov 14, 05
|
| 09:04 ET |
BARACLUDE(TM) (entecavir) Two-year Data Analysis Did Not Detect Emergence of Resistance in Nucleoside-Naive Chronic Hepatitis B Patients
|
|
Oct 20, 05
|
| 14:18 ET |
Distinguished Achievement Awards Go to Seven Leading Researchers for Groundbreaking Discoveries; $6.5 Million in No-Strings-Attached Grants Support 13 Scientists for Cutting Edge Biomedical Research Across Three Continents
|
|
Oct 18, 05
|
| 08:04 ET |
Bristol-Myers Squibb and Merck Joint Statement on Regulatory Status of PARGLUVA(TM) (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes
|
|
Oct 11, 05
|
| 13:10 ET |
Bristol-Myers Squibb Names Richard Willard Senior Vice President and General Counsel
|
|
Sep 27, 05
|
| 17:30 ET |
Bristol-Myers Squibb Invites Others to Join in Expansion of Pediatric AIDS Corps in Africa
|
|
Sep 20, 05
|
| 09:20 ET |
Bristol-Myers Squibb Company Announces Planned Departure of Donald Hayden, Executive Vice President and President, Americas
|
|
| 09:18 ET |
Bristol-Myers Squibb Company Reorganizes Operating Units, Promoting Lamberto Andreotti to Executive Vice President and President, Worldwide Pharmaceuticals
|
|
| 08:00 ET |
Bristol-Myers Squibb Tour of Hope(TM) Team Joins Lance Armstrong to Kick Off 3,300-Mile Cycling Journey to Raise Awareness About Cancer Clinical Trials
|
|
Sep 13, 05
|
| 17:43 ET |
Bristol-Myers Squibb Announces Dividend
|
|
| 16:30 ET |
Bristol-Myers Squibb Names Louis J. Freeh to Board of Directors
|
|
Sep 09, 05
|
| 15:20 ET |
Bristol-Myers Squibb and Merck Joint Statement on FDA Advisory Committee Vote on PARGLUVA(TM) (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes
|
|
Sep 06, 05
|
| 16:13 ET |
Bristol-Myers Squibb Statement on FDA Advisory Committee Vote on ORENCIA(R) (Abatacept), an Investigational Selective Modulator of T-Cell Co-Stimulation for Rheumatoid Arthritis
|
|
Aug 31, 05
|
| 16:30 ET |
Bristol-Myers Squibb Company Closes Previously Announced Sale of U.S. and Canadian Consumer Medicines Business
|
|
Aug 30, 05
|
| 07:00 ET |
ImClone Systems Incorporated and Bristol-Myers Squibb File Supplemental Biologics License Application for ERBITUX(R) for Treatment of Head and Neck Cancer
|
|
Aug 10, 05
|
| 13:34 ET |
New Enfamil(R) Gentlease(TM) LIPIL(R) Now Available for Babies With Fussiness or Gas
|
|
Jul 28, 05
|
| 06:58 ET |
Bristol-Myers Squibb Announces Financial Results for the Second Quarter and First Half of 2005, with Businesses on Plan, Led By Pharmaceutical Growth Drivers
|
|
Jul 19, 05
|
| 16:07 ET |
Bristol-Myers Squibb Company to Announce Results for the Second Quarter and First Half of 2005 on July 28
|
|
Jul 14, 05
|
| 16:12 ET |
Bristol-Myers Squibb Signs Agreement for Previously Announced Sale of Its U.S. and Canadian Consumer Medicines Business
|
|
Jun 21, 05
|
| 22:00 ET |
Bristol-Myers Squibb Company Signs Manufacturing Agreement With Celltrion
|
|
Jun 20, 05
|
| 12:13 ET |
Bristol-Myers Squibb Tour of Hope(TM) Announces Team of Cancer Advocates to Join Lance Armstrong in Cross Country Journey in Support of Cancer Research
|
|
Jun 15, 05
|
| 14:35 ET |
Bristol-Myers Squibb Announces Agreement With the U.S. Attorney's Office in New Jersey
|
|
| 14:35 ET |
James D. Robinson III Elected Non-Executive Chairman Of The Board Of Bristol-Myers Squibb; Peter R. Dolan Continues As CEO
|
|
Jun 12, 05
|
| 17:20 ET |
Phase III and II Data for Investigational Medicine PARGLUVA(TM) (muraglitazar) Highlighted in Late-Breaking Presentation at Annual Scientific Sessions of the American Diabetes Association
|
|
Jun 09, 05
|
| 08:31 ET |
New Phase III Efficacy Data on Investigational Biologic Abatacept Presented at EULAR Meeting
|
|
May 25, 05
|
| 08:31 ET |
New Investigational Data Using Intramuscular Administration of Aripiprazole in Patients with Acute Bipolar Mania and Schizophrenia
|
|
May 20, 05
|
| 16:46 ET |
New Study Shows Investigational Compound Muraglitazar Significantly Lowered Blood Glucose Levels As Measured By A1C Reduction in Patients With Type 2 Diabetes
|
|
May 11, 05
|
| 16:56 ET |
Bristol-Myers Squibb Closes Previously Announced Sale of Its OTN Distribution Business to One Equity Partners LLC
|
|
May 09, 05
|
| 17:44 ET |
Bristol-Myers Squibb Revises Certain Financial Information With Filing of Its First Quarter 2005 Form 10-Q
|
|
| 09:00 ET |
'Aim for the B' Targets Need to Increase Education and Awareness for Chronic Hepatitis B
|
|
Apr 28, 05
|
| 07:11 ET |
Bristol-Myers Squibb Reports First Quarter 2005 Results in Line With Expectations and Increased Investment in Research and Growth Products
|
|
Apr 27, 05
|
| 09:02 ET |
Bristol-Myers Squibb Announces Settlement of Derivative Litigation Against Current and Former Officers and Directors
|
|
Apr 19, 05
|
| 09:57 ET |
Bristol-Myers Squibb to Announce First Quarter Results for 2005 on April 28, 2005
|
|
Apr 05, 05
|
| 06:35 ET |
Bristol-Myers Squibb Joins National Program to Help Uninsured Americans Get the Prescription Medications They Need
|
|
Apr 01, 05
|
| 08:30 ET |
Bristol-Myers Squibb Announces Results of Tender Offer And Intention to Redeem All Remaining 2006 Notes
|
|
Mar 30, 05
|
| 17:30 ET |
Bristol-Myers Squibb Prices Tender Offer
|
|
Mar 29, 05
|
| 19:38 ET |
U.S. Food and Drug Administration (FDA) Approves BARACLUDE(TM) (entecavir) for Treatment of Chronic Hepatitis B
|
|
Mar 23, 05
|
| 09:01 ET |
Bristol-Myers Squibb Announces Debt Tender Offer
|
|
Mar 22, 05
|
| 13:13 ET |
Bristol-Myers Squibb Extends Assistance to State AIDS Drug Assistance Programs
|
|
| 10:54 ET |
Lance Armstrong and Cancer Community Seek Cyclists for 2005 Bristol-Myers Squibb Tour of Hope(TM) National Team
|
|
Mar 07, 05
|
| 11:17 ET |
ABILIFY(R) (aripiprazole) Granted Approval for New Indication
|
|
Mar 01, 05
|
| 16:32 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Jan 27, 05
|
| 07:33 ET |
Bristol-Myers Squibb Announces Fourth Quarter and Twelve Months Sales and Earnings for 2004
|
|
Jan 24, 05
|
| 12:00 ET |
Bristol-Myers Squibb to Announce Fourth Quarter and Twelve Months Results for 2004 on January 27, 2005
|
|
Jan 13, 05
|
| 13:24 ET |
Sod-Turning Ceremony Marks Start of Construction of First Pediatric HIV/AIDS Medical Center in Swaziland
|
|
Jan 12, 05
|
| 10:45 ET |
Bristol-Myers Squibb Plans to Divest U.S. and Canadian Consumer Medicines Business
|
|
Jan 03, 05
|
| 17:23 ET |
Bristol-Myers Squibb Names James M. Cornelius to Board of Directors
|
|
Dec 23, 04
|
| 12:00 ET |
Bristol-Myers Squibb Provides Regulatory Update for Muraglitazar and Abatacept
|
|
Dec 20, 04
|
| 08:30 ET |
Bristol-Myers Squibb and Gilead Sciences Establish U.S. Joint Venture to Develop and Commercialize Fixed-Dose Combination of Three HIV Medicines
|
|
Dec 14, 04
|
| 09:23 ET |
Bristol-Myers Squibb to Sell Oncology Therapeutics Network
|
|
Dec 10, 04
|
| 16:13 ET |
Bristol-Myers Squibb Announces Intent to Pursue FDA Approval of Pravachol(R) (pravastatin sodium) as an OTC Cholesterol-Lowering Therapy
|
|
Dec 07, 04
|
| 17:54 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Dec 05, 04
|
| 19:30 ET |
Phase I Study Results of Investigational Agent BMS-354825 in Patients With Imatinib-Resistant or Intolerant Chronic Myelogenous Leukemia Presented at the 46th Annual Meeting of the American Society of Hematology
|
|
Nov 30, 04
|
| 16:08 ET |
Bristol-Myers Squibb Invites Yahoo!'s Global Audience to Shine a Light on the HIV/AIDS Crisis on World AIDS Day
|
|
Nov 17, 04
|
| 09:15 ET |
Bristol-Myers Squibb Showcases Pipeline at Research and Development Overview Meeting
|
|
Nov 11, 04
|
| 10:00 ET |
Bristol-Myers Squibb to Host Research and Development Overview with Financial Analysts on November 17, 2004
|
|
Nov 08, 04
|
| 06:01 ET |
Bristol-Myers Squibb Company and Medarex Form Global Development and Commercialization Collaboration for MDX-010
|
|
Nov 01, 04
|
| 10:40 ET |
Bristol-Myers Squibb Foundation and China Foundation for Hepatitis Prevention and Control Collaborate to Fight One of China's Most Pressing Health Problems
|
|
| 10:35 ET |
UPDATE: Investigational Hepatitis B Agent entecavir Demonstrated Statistically Significant Improvement Over lamivudine in Chronically Infected Hepatitis B Patients
|
|
Oct 29, 04
|
| 17:01 ET |
Use of Investigational Agent Entecavir Demonstrated Statistically Significant Improvement in Liver Histology and Viral Suppression Compared to Lamivudine in Chronically Infected Hepatitis B E-Antigen (HBeAg) Positive Patients
|
|
| 07:53 ET |
Bristol-Myers Squibb Announces Third Quarter and Nine Months Sales and Earnings for 2004
|
|
Oct 28, 04
|
| 15:30 ET |
Bristol-Myers Squibb Appoints Dr. Elliott Sigal Chief Scientific Officer and President of The Pharmaceutical Research Institute
|
|
Oct 27, 04
|
| 06:00 ET |
Pediatric HIV/AIDS Medical Centers to be Built in African Nations of Lesotho and Swaziland
|
|
Oct 26, 04
|
| 10:08 ET |
Bristol-Myers Squibb Mourns the Loss of James B.D. Palmer, F.R.C.P., Chief Scientific Officer and President of the Pharmaceutical Research Institute
|
|
Oct 25, 04
|
| 16:30 ET |
Bristol-Myers Squibb to Announce Third Quarter Earnings on October 29, 2004
|
|
Oct 22, 04
|
| 12:52 ET |
Elliott Sigal Named Acting President of Bristol-Myers Squibb Pharmaceutical Research Institute
|
|
Oct 18, 04
|
| 08:32 ET |
Phase III Clinical Trial Results of Investigational Biologic Abatacept Demonstrated Clinical Activity in Patients With Rheumatoid Arthritis
|
|
Oct 17, 04
|
| 18:15 ET |
Phase III Clinical Trial Results of Investigational Biologic Abatacept Demonstrated Clinical Activity in Patients With Rheumatoid Arthritis
|
|
Oct 06, 04
|
| 11:46 ET |
Expecta(TM) LIPIL(R) DHA Supplement Now Available For Pregnant and Nursing Women
|
|
Oct 04, 04
|
| 10:02 ET |
Bristol-Myers Squibb Submits Applications in U.S. and Europe to Market Entecavir, an Investigational Antiviral Treatment For Chronic Hepatitis B Infection
|
|
Sep 28, 04
|
| 09:37 ET |
Parents Can Start Saving for Their Children's Education When Purchasing Enfamil(R) Formulas
|
|
Sep 22, 04
|
| 11:01 ET |
Bristol-Myers Squibb Tour of Hope(TM) Team, Lance Armstrong to Embark on Cross-Country Cycling Journey from Los Angeles
|
|
Sep 14, 04
|
| 17:04 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Aug 26, 04
|
| 10:00 ET |
New Long-Term Data Provide Guidance on the Use of Sustiva(R) (Efavirenz) in HIV-Treatment-Naive Patients
|
|
Aug 04, 04
|
| 12:00 ET |
Bristol-Myers Squibb Statement on SEC Settlement
|
|
Aug 02, 04
|
| 08:50 ET |
Bristol-Myers Squibb Company Extends Exchange Offer on 4.00% Senior Notes
|
|
Jul 30, 04
|
| 10:04 ET |
Bristol-Myers Squibb to Settle Securities Class Action Litigation
|
|
Jul 29, 04
|
| 07:12 ET |
Bristol-Myers Squibb Announces Second Quarter and Six Months Sales and Earnings for 2004
|
|
Jul 22, 04
|
| 15:36 ET |
Bristol-Myers Squibb to Announce 2004 2nd Quarter Earnings on July 29, 2004
|
|
Jul 14, 04
|
| 08:34 ET |
REYATAZ(R) (atazanavir sulfate) Granted Approval For Use With Low-Dose Ritonavir in Treatment-Experienced HIV-Infected Patients
|
|
Jul 12, 04
|
| 08:22 ET |
New Mali Center Joins Five Other Novel HIV/AIDS Community-Based Treatment Support Programs
|
|
Jun 28, 04
|
| 09:06 ET |
Bristol-Myers Squibb Announces Expected Increases In Legal Reserves Of $400 Million
|
|
Jun 08, 04
|
| 17:00 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Jun 07, 04
|
| 07:02 ET |
ABILIFY(R) (aripiprazole) Approved For Marketing in Europe for the Treatment of Schizophrenia
|
|
Jun 01, 04
|
| 09:49 ET |
Bristol-Myers Squibb Tour of Hope(TM) Announces 20 Cancer Survivors, Loved Ones and Experts to Join Lance Armstrong in Raising Awareness of Cancer Clinical Trials
|
|
May 17, 04
|
| 08:32 ET |
Bristol-Myers Squibb and Solvay Pharmaceuticals in Development and Commercialization Agreement Involving Novel Obesity Compound
|
|
May 07, 04
|
| 15:44 ET |
Lesotho Launches Its Public Sector ARV Learning Center With $3.9 Million In Support From Bristol-Myers Squibb's Secure the Future Program
|
|
May 05, 04
|
| 15:01 ET |
New Data and Analyses Demonstrate ABILIFY(R) (Aripiprazole) Effective at Treating Patients With Acute Manic and Mixed Episodes of Bipolar Disorder
|
|
| 12:00 ET |
Clinical Study Shows Intramuscular Administration of Aripiprazole (Abilify(R)) Significantly Improves Acute Agitation in Patients With Schizophrenia
|
|
Apr 28, 04
|
| 07:37 ET |
Bristol-Myers Squibb Announces First Quarter Sales and Earnings For 2004
|
|
| 07:14 ET |
Bristol-Myers Squibb and Merck Announce Global Development And Commercialization Alliance for Muraglitazar, a Novel Compound For Diabetes
|
|
Apr 27, 04
|
| 07:54 ET |
Bristol-Myers Squibb Statement on Paraplatin Settlement
|
|
Apr 21, 04
|
| 12:00 ET |
Bristol-Myers Squibb to Announce 2004 First Quarter Earnings on April 28, 2004
|
|
| 08:35 ET |
Bristol-Myers Squibb and Metrika Announce Exclusive U.S. Supply Agreement for A1cNow(R) Diabetes Monitor
|
|
Apr 20, 04
|
| 08:03 ET |
Bristol-Myers Squibb and Pierre Fabre Medicament S.A. Enter Into Agreement to Develop and Commercialize Oncology Treatment Javlor(R) (vinflunine)
|
|
Apr 15, 04
|
| 12:19 ET |
Cutting Edge HIV/AIDS Monitoring Research Funded by Bristol-Myers Squibb Leads to Significant Cost Savings for African Nations
|
|
Apr 06, 04
|
| 09:14 ET |
Bristol-Myers Squibb Announces Acquisition of Acordis Speciality Fibres Business
|
|
Mar 31, 04
|
| 09:50 ET |
Bristol-Myers Squibb Statement Regarding Paraplatin Pediatric Submission and Federal Appeals Court Reversal on Patent
|
|
Mar 17, 04
|
| 09:49 ET |
Lance Armstrong and Cancer Community Seek Cyclists to Participate in 2004 Bristol-Myers Squibb Tour of Hope(TM)
|
|
Mar 08, 04
|
| 10:54 ET |
New Study Demonstrates the Benefits of Intensive Statin Therapy In Patients Hospitalized with Acute Coronary Syndrome
|
|
Mar 02, 04
|
| 17:47 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Feb 12, 04
|
| 16:39 ET |
ERBITUX(TM) (Cetuximab) Receives FDA Approval to Treat Irinotecan Refractory Or Intolerant Metastatic Colorectal Cancer
|
|
Feb 10, 04
|
| 10:31 ET |
Women In Government Announces Partnership With Bristol-Myers Squibb Foundation to Convene First Ever Summit of State Offices of Women's Health
|
|
Jan 29, 04
|
| 08:16 ET |
Bristol-Myers Squibb Announces Fourth Quarter And Twelve Months Sales and Earnings for 2003
|
|
Jan 27, 04
|
| 12:54 ET |
Bristol-Myers Squibb to Announce 2003 Fourth Quarter and Full Year Earnings On January 29, 2004
|
|
| 10:47 ET |
$4.6 Million in 'Freedom to Discover' Grants Awarded To 10 Leading Medical Research Institutions
|
|
Dec 16, 03
|
| 01:45 ET |
Mead Johnson & Company Confirms Sale of Global Adult Nutritional Business
|
|
Dec 09, 03
|
| 17:06 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Dec 03, 03
|
| 12:53 ET |
Bristol-Myers Squibb Commits to Funding New Pediatric HIV/AIDS Center in Africa
|
|
Nov 24, 03
|
| 06:30 ET |
ImClone Systems Incorporated and Bristol-Myers Squibb File New Drug Submission With Health Canada for Use of ERBITUX(TM) (Cetuximab) for Treatment of EGFR-Expressing Irinotecan-Refractory Metastatic Colorectal Cancer
|
|
Oct 23, 03
|
| 08:18 ET |
Bristol-Myers Squibb Announces Third Quarter and Nine Months Sales and Earnings for 2003
|
|
Oct 17, 03
|
| 09:45 ET |
Bristol-Myers Squibb to Announce Third Quarter Earnings On October 23, 2003
|
|
Oct 13, 03
|
| 08:31 ET |
Bristol-Myers Squibb and Corgentech Enter Global Agreement to Develop and Commercialize Novel Cardiovascular Therapy
|
|
Oct 11, 03
|
| 17:20 ET |
Lance Armstrong Leads the Bristol-Myers Squibb Tour of Hope(TM) To Raise Awareness About the Promise of Cancer Research
|
|
Oct 10, 03
|
| 19:55 ET |
ImClone Systems and Bristol-Myers Squibb Announce Acceptance of ERBITUX(TM) (Cetuximab) Biologics License Application for Review by the U.S. Food and Drug Administration
|
|
Sep 29, 03
|
| 16:35 ET |
Public Festival to Welcome Lance Armstrong & the Tour of Hope Team to Washington After Cross-Country Cycling Journey Grand Finale - Saturday, October 18 - The Ellipse
|
|
Sep 24, 03
|
| 17:47 ET |
Bristol-Myers Squibb Announces Offering of Convertible Senior Debentures
|
|
Sep 23, 03
|
| 08:30 ET |
Bristol-Myers Squibb Launches Comprehensive Line of ChoiceDM(TM) Diabetic Care Products
|
|
Sep 10, 03
|
| 08:31 ET |
Bristol-Myers Squibb and QDose Announce Collaboration to Develop Inhaled Insulin for the Treatment of Diabetes
|
|
Sep 09, 03
|
| 17:18 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Sep 08, 03
|
| 15:32 ET |
FDA Approves ABILIFY(TM) (Aripiprazole) Supplemental New Drug Application (sNDA) for Maintaining Stability in Patients With Schizophrenia
|
|
Sep 02, 03
|
| 07:31 ET |
Bristol-Myers Squibb Provides Update on Garenoxacin Development
|
|
Aug 27, 03
|
| 08:00 ET |
Bristol-Myers Squibb and Flamel Technologies Announce Licensing Agreement For Basulin(R)
|
|
Aug 21, 03
|
| 12:08 ET |
Bristol-Myers Squibb Tour of Hope(TM) Announces Team Members To Ride Across America, Joining Lance Armstrong To Raise Awareness of Cancer Research
|
|
Aug 14, 03
|
| 13:27 ET |
ImClone Systems Incorporated and Bristol-Myers Squibb Announce Submission of Biologics License Application for ERBITUX(TM) (Cetuximab) To Treat Irinotecan-Refractory Metastatic Colorectal Cancer
|
|
Jul 24, 03
|
| 08:49 ET |
Bristol-Myers Squibb Announces Second Quarter and Six Months Sales and Earnings for 2003
|
|
Jul 22, 03
|
| 16:47 ET |
Bristol-Myers Squibb Reviews Sales And Marketing Compliance
|
|
Jul 21, 03
|
| 15:00 ET |
Bristol-Myers Squibb to Announce Second Quarter Earnings on July 24, 2003
|
|
Jul 16, 03
|
| 11:30 ET |
Supplemental New Drug Application Submitted for ABILIFY(TM)(aripiprazole) For the Treatment of Acute Bipolar Mania
|
|
Jul 01, 03
|
| 16:03 ET |
Bristol-Myers Squibb and Lance Armstrong Partner in Unprecedented Tour of Hope(TM) to Raise Awareness of Cancer Research
|
|
Jun 25, 03
|
| 08:30 ET |
Bristol-Myers Squibb Receives FDA Approval of PRAVIGARD(TM) PAC (Buffered Aspirin and Pravastatin Sodium) Tablets
|
|
Jun 19, 03
|
| 17:11 ET |
First Pediatric HIV/AIDS Center to Open in Botswana With Major Support From Bristol-Myers Squibb's Secure the Future Program
|
|
Jun 10, 03
|
| 17:53 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Jun 05, 03
|
| 16:49 ET |
ImClone Systems and Bristol-Myers Squibb Meet With The FDA To Discuss ERBITUX(TM) (cetuximab) Regulatory Filing
|
|
Jun 04, 03
|
| 08:31 ET |
Relief for Tension Headache Pain - Bristol-Myers Squibb Launches Excedrin(R) Tension Headache -
|
|
Jun 02, 03
|
| 09:03 ET |
Bristol-Myers Squibb Epothilone Phase II Findings Show Activity in Metastatic Breast Cancer and Non-Small Cell Lung Cancer
|
|
May 20, 03
|
| 18:00 ET |
Results From New Clinical Studies: Aripiprazole Significantly Improved Symptoms of Acute Bipolar Mania
|
|
May 19, 03
|
| 18:00 ET |
Aripiprazole Demonstrates Better Weight Change Profile, Comparable Efficacy In Schizophrenia Compared to Olanzapine in New Study
|
|
May 13, 03
|
| 17:49 ET |
FDA Antiviral Advisory Committee Recommends Approval For Bristol-Myers Squibb's Investigational Protease Inhibitor Reyataz(TM)(Atazanavir)
|
|
May 02, 03
|
| 11:14 ET |
Bristol-Myers Squibb Company Announces Acquisition of Only FDA-Approved Short-Term Treatment for Apnea of Prematurity
|
|
Apr 29, 03
|
| 08:35 ET |
Bristol-Myers Squibb Announces First Quarter Sales and Earnings For 2003
|
|
Apr 24, 03
|
| 10:27 ET |
Bristol-Myers Squibb to Announce First Quarter Earnings on April 29, 2003
|
|
Apr 14, 03
|
| 11:03 ET |
Bristol-Myers Squibb Announces U.S. Food And Drug Administration Approval Of Glucophage(R) XR (Metformin HCl Extended Release Tablets) 750 MG TABLET
|
|
Apr 02, 03
|
| 11:45 ET |
International Analyses Show Plavix(R)/Iscover(R) (Clopidogrel Bisulphate) Has A Favorable Cost Effectiveness Ratio for ACS Patients Without ST-Segment Elevation (Unstable Angina Or Non Q-Wave MI); Data presented at American College of Cardiology 52nd Annu
|
|
Apr 01, 03
|
| 00:30 ET |
Clopidogrel Studied in One of the Largest Clinical Trial Programs in the Fight Against Atherothrombosis
|
|
Mar 18, 03
|
| 22:08 ET |
Bristol-Myers Squibb Files Restatement Documents With the Securities and Exchange Commission
|
|
Mar 10, 03
|
| 08:14 ET |
Bristol-Myers Squibb Announces Restatement, Reports 2002 Full-Year Results and Reiterates Earnings Guidance for 2003
|
|
Mar 07, 03
|
| 12:00 ET |
Bristol-Myers Squibb Announces Agreements With State Attorneys General And Federal Trade Commission
|
|
Mar 05, 03
|
| 11:06 ET |
Minority Students from Nation's Top Medical Schools Discuss Health Disparities and Medical Careers with High School Students
|
|
Mar 04, 03
|
| 16:49 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Feb 27, 03
|
| 08:29 ET |
Bristol-Myers Squibb to Announce Results of Restatement and 2002 Earnings On March 10, 2003
|
|
Feb 25, 03
|
| 09:00 ET |
Supplemental New Drug Application (sNDA) for Long-Term Schizophrenia Treatment Submitted for ABILIFY(TM) (aripiprazole)
|
|
Jan 28, 03
|
| 10:58 ET |
Bristol-Myers Squibb Announces Injectable Acetaminophen Licencing Agreement; - Agreement Expands Existing Pain Management Portfolio -
|
|
Jan 17, 03
|
| 07:30 ET |
Bristol-Myers Squibb Provides Earnings Guidance For 2003
|
|
Jan 07, 03
|
| 10:44 ET |
Bristol-Myers Squibb to Settle Antitrust Litigation
|
|
Dec 03, 02
|
| 18:05 ET |
Bristol-Myers Squibb Board of Directors Declares Dividend
|
|
Nov 18, 02
|
| 10:44 ET |
ABILIFY(TM) (Aripiprazole) Approved by U.S. Food and Drug Administration For Treatment of Schizophrenia
|
|
| 10:40 ET |
PROSPER - The PROspective Study of Pravastatin in the Elderly at Risk
|
|
| 10:39 ET |
Landmark Three-Year Clinical Trial Confirms for the First Time the Benefit of Pravastatin in Reducing the Risk of Heart Attack and Coronary Death in Older Patients
|
|
Nov 15, 02
|
| 16:40 ET |
ABILIFY(TM) (aripiprazole) Approved By U.S. Food and Drug Administration For Treatment of Schizophrenia
|
|
| 08:28 ET |
Bristol-Myers Squibb Company Announces the Expected Timing For Filing Its Third Quarter 2002 10-Q
|
|
Nov 06, 02
|
| 15:36 ET |
Bristol-Myers Squibb Announces New Senior Leadership Team - New and Recent Hires Shape Process of Management Restructure -
|
|
Oct 31, 02
|
| 11:25 ET |
U.S. Food and Drug Administration Approves Pravachol (R) (Pravastatin Sodium) for Use in Pediatric Patients
|
|
Oct 26, 02
|
| 09:30 ET |
Data Show Bristol-Myers Squibb's BMS-188667 (CTLA4Ig), An Investigational Costimulation Blocker, Provided Improvement in Rheumatoid Arthritis Activity When Added to Methotrexate Therapy
|
|
| 09:30 ET |
Data Suggest Bristol-Myers Squibb Investigational Costimulation Blocker, BMS-188667 (CTLA4Ig), May Have Potential in Rheumatoid Arthritis Patients Inadequately Responding to Etanercept Alone
|
|
Oct 24, 02
|
| 09:24 ET |
Bristol-Myers Squibb Company to Restate Sales and Earnings For Periods Affected by Inventory Buildup in US Pharmaceuticals Unit
|
|
Oct 22, 02
|
| 09:57 ET |
Bristol-Myers Squibb Receives FDA Approval of Metaglip(TM) (Glipizide and Metformin HCl Tablets) for Type 2 Diabetes
|
|
Oct 21, 02
|
| 09:03 ET |
Bristol-Myers Squibb Appoints James Palmer to Position of Chief Scientific Officer
|
|
Oct 11, 02
|
| 18:49 ET |
Bristol-Myers Squibb Receives FDA Letter For Vanlev(TM)
|
|
| 12:56 ET |
FDA Approves New Indication for Glucovance(R) (Glyburide and Metformin HCL Tablets)
|
|
Oct 09, 02
|
| 13:45 ET |
Bristol-Myers Squibb Statement
|
|
Oct 07, 02
|
| 08:30 ET |
New Headache Relief - No Water Needed
|
|
Sep 27, 02
|
| 12:00 ET |
Bristol-Myers Squibb Early Access Program Can Provide Investigational Protease Inhibitor Atazanavir for Eligible Patients With HIV
|
|
Sep 26, 02
|
| 09:22 ET |
Bristol-Myers Squibb to Reacquire U.S. Co-Promotion Rights for TEQUIN(R) From Schering-Plough
|
|
Sep 24, 02
|
| 09:38 ET |
Bristol-Myers Squibb Named Best in Class for Child Care By Working Mother Magazine
|
|
Sep 18, 02
|
| 11:34 ET |
FDA Approves Avapro(R) (irbesartan) for the Treatment of Diabetic Nephropathy (Kidney Disease) in Patients With High Blood Pressure and Type 2 Diabetes
|
|
Sep 17, 02
|
| 13:00 ET |
Bristol-Myers Squibb Confirms Previous Earnings Guidance and Progress of Inventory Workdown
|
|
Sep 10, 02
|
| 17:41 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Sep 03, 02
|
| 08:32 ET |
U.S. FDA Issues Approvable Letter for ABILIFY(TM)
|
|
Aug 29, 02
|
| 15:07 ET |
Bristol-Myers Squibb Statement on SEC Investigation
|
|
Jul 23, 02
|
| 08:34 ET |
Bristol-Myers Squibb Announces Second Quarter and Six Months Sales & Earnings
|
|
Jul 16, 02
|
| 10:30 ET |
Bristol-Myers Squibb to Announce Second Quarter Earnings On Tuesday, July 23, 2002
|
|
Jul 11, 02
|
| 15:45 ET |
Bristol-Myers Squibb Response Statement Regarding Wholesaler Inventory Issue and SEC Inquiry
|
|
| 12:00 ET |
Data Show HIV Patients Switched to Bristol-Myers Squibb Investigational Protease Inhibitor May Have Significant Reductions In Cholesterol and Triglyceride Levels
|
|
Jun 27, 02
|
| 08:30 ET |
CPMP Recommends Granting Marketing Authorization in the European Union For Plavix(R)/Iscover(R) (clopidogrel) for the Treatment of Acute Coronary Syndrome with Non ST Segment Elevation
|
|
Jun 26, 02
|
| 15:11 ET |
European Commission Approves Irbesartan (Aprovel(TM)/Karvea(TM)) for the Treatment of Diabetic Renal Disease
|
|
Jun 20, 02
|
| 09:26 ET |
Bristol-Myers Squibb Executing on Plan to Reduce Wholesaler Inventory
|
|
Jun 15, 02
|
| 13:00 ET |
New Oral Antidiabetic Agent May Offer Treatment Advantage for People With Type 2 Diabetes
|
|
Jun 13, 02
|
| 10:05 ET |
Bristol-Myers Squibb Confirms FDA Cardiovascular and Renal Drugs Advisory Committee to Review Vanlev NDA for Hypertension
|
|
Jun 04, 02
|
| 16:05 ET |
Bristol-Myers Squibb Announces Dividend
|
|
May 22, 02
|
| 12:05 ET |
Data Demonstrate Aripiprazole Significantly Improved Symptoms Of Acute Mania in Patients With Bipolar Disorder
|
|
| 12:05 ET |
Studies Demonstrated Long-Term Effect of Aripiprazole in Treatment of Schizophrenia
|
|
| 12:05 ET |
Study Showed Patients With Schizophrenia Switched to Aripiprazole From Other Antipsychotics Demonstrated Improvement in Symptoms and Reduction in Side Effects
|
|
May 19, 02
|
| 17:00 ET |
Data Presented on Anti-Tumor Activity of ERBITUX (TM) (cetuximab) As a Single-Agent and in Combination With Widely-Used Three-Drug Chemotherapy in Colorectal Carcinoma
|
|
| 12:00 ET |
Data Presented on Study of ERBITUX(TM) (cetuximab) Combined with Docetaxel In Patients With Advanced Non-Small Cell Lung Cancer
|
|
May 18, 02
|
| 17:45 ET |
Study Demonstrates Utility of ERBITUX (TM) (Cetuximab) Combined With Cisplatin for Treatment of Refractory Head and Neck Cancer
|
|
Apr 25, 02
|
| 09:12 ET |
Bristol-Myers Squibb Announces First Quarter Sales & Earnings
|
|
Apr 18, 02
|
| 10:45 ET |
Bristol-Myers Squibb to Announce First Quarter Earnings On Thursday, April 25, 2002
|
|
Apr 16, 02
|
| 08:02 ET |
Bristol-Myers Squibb Announces Key Appointments In Business/Corporate Development
|
|
Apr 03, 02
|
| 16:16 ET |
Bristol-Myers Squibb Chairman and CEO, Peter R. Dolan Announces Actions to Improve Operating and Financial Performance, Including Management and Organizational Changes
|
|
Mar 15, 02
|
| 12:00 ET |
American College of Cardiology, American Heart Association Announce New Guidelines Recommending Plavix(R) (clopidogrel bisulfate) for Acute and Continued Treatment of Unstable Angina or Heart Attack (non Q-wave myocardial infarction)
|
|
Mar 12, 02
|
| 01:30 ET |
CPMP Recommends Granting Marketing Authorization in the European Union for Irbesartan in the Treatment of Diabetic Renal Disease
|
|
Mar 05, 02
|
| 17:30 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Feb 12, 02
|
| 14:48 ET |
Bristol-Myers Squibb Responds to ImClone Systems, Inc.
|
|
Feb 05, 02
|
| 18:13 ET |
Bristol-Myers Squibb Proposes Restructuring Relationship With ImClone Systems, Inc.
|
|
Jan 24, 02
|
| 17:11 ET |
Bristol-Myers Squibb Announces Sales and Earnings For Fourth Quarter and Full-Year 2001
|
|
Jan 17, 02
|
| 17:13 ET |
Bristol-Myers Squibb to Announce 2001 Fourth Quarter And Year-End Earnings on Thursday, January 24
|
|
Jan 15, 02
|
| 17:15 ET |
Bristol-Myers Squibb Names Elliott Sigal to New Position in Clinical And Pharmaceutical Development
|
|
Jan 09, 02
|
| 11:52 ET |
Bristol-Myers Squibb Appoints Thomas J. Pickard As New Head of Corporate Security
|
|
Jan 08, 02
|
| 17:00 ET |
Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval of Pravachol(R) (Pravastatin Sodium) 80 mg
|
|
Jan 07, 02
|
| 16:58 ET |
New Research Points to Key Role of Imaging Test in Reducing Higher Cardiac Event Rates and Improving Outcomes in Patients With Diabetes
|
|
Dec 18, 01
|
| 16:48 ET |
Bristol-Myers Squibb Re-Files VANLEV(TM) for Hypertension With FDA
|
|
Dec 17, 01
|
| 16:50 ET |
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Marketing Authorization Application Submission for Aripiprazole
|
|
| 16:47 ET |
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Marketing Authorization Application Submission for Aripiprazole
|
|
| 16:44 ET |
Bristol-Myers Squibb Presents Data From Potential Best in Class Compounds in Diverse Infectious Disease Drug Pipeline
|
|
Dec 13, 01
|
| 16:54 ET |
Bristol-Myers Squibb Announces Two Percent Increase In Its Common Stock Dividend
|
|
| 16:47 ET |
Bristol-Myers Squibb Provides EPS Guidance For 2002
|
|
| 14:58 ET |
Bristol Myers Squibb to Hold Conference Call for Analysts Today at 5:00 P.M. (EST)
|
|
Nov 28, 01
|
| 09:37 ET |
Bristol-Myers Squibb Appoints New Head of Corporate Development - Tamar Howson Joins as Senior Vice President -
|
|
Nov 27, 01
|
| 07:00 ET |
Happy Holidays? Not When Headaches Hit!
|
|
Nov 16, 01
|
| 10:30 ET |
Bristol-Myers Squibb Completes Sale of Clairol to Procter & Gamble
|
|
Nov 15, 01
|
| 16:42 ET |
Bristol-Myers Squibb Medical Imaging Announces Comprehensive Set of Agreements With Amersham Health
|
|
| 09:32 ET |
Bristol-Myers Squibb Medical Imaging Announces Comprehensive Set of Agreements With Amersham Health
|
|
Nov 07, 01
|
| 16:56 ET |
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Submit New Drug Application for Aripiprazole
|
|
| 10:58 ET |
Bristol-Myers Squibb Announces Unprecendented Plan To Submit Global Regulatory Filings For Five Potential Blockbusters Within 12 Months
|
|
Nov 02, 01
|
| 16:44 ET |
Bristol-Myers Squibb Company Focus on Pharmaceuticals: a Discovery & Development Update
|
|
Nov 01, 01
|
| 16:55 ET |
Bristol-Myers Squibb and ImClone Systems Announce Completion of Rolling Biologics License Application Filing for Erbitux(TM), Formerly IMC-C225, To Treat Irinotecan-Refractory Colorectal Carcinoma
|
|
Oct 29, 01
|
| 08:51 ET |
Bristol-Myers Squibb Accepts Shares in Tender Offer for ImClone Systems, Announces Preliminary Results
|
|
Oct 25, 01
|
| 16:51 ET |
Bristol-Myers Squibb Offers to Work With U.S. Government to Combat Bioterrorism
|
|
Oct 23, 01
|
| 13:45 ET |
Bristol-Myers Squibb Reports Third Quarter and Nine Month Sales & Earnings
|
|
Oct 15, 01
|
| 10:53 ET |
Bristol-Myers Squibb to Announce Third Quarter and Nine Month Earnings On Tuesday, October 23, 2001
|
|
Oct 09, 01
|
| 09:28 ET |
Bristol-Myers Squibb Named One of 10 Best Companies for Working Mothers By Working Mother Magazine
|
|
Oct 02, 01
|
| 07:03 ET |
Bristol-Myers Squibb Acquires Dupont Pharmaceuticals Company
|
|
Sep 27, 01
|
| 09:05 ET |
Atlanta Woman Receives National Award For Her Great Comeback From Ostomy Surgery
|
|
Sep 25, 01
|
| 09:12 ET |
Bristol-Myers Squibb to Re-File VANLEV NDA
|
|
Sep 19, 01
|
| 12:24 ET |
Bristol-Myers Squibb Reconfirms Previous Earnings Expectations
|
|
| 12:13 ET |
Bristol-Myers Squibb and ImClone Systems Enter Into Landmark Commercialization Agreement for Important Investigational Cancer Drug IMC-C225
|
|
Sep 17, 01
|
| 12:39 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Sep 13, 01
|
| 15:43 ET |
Peter R. Dolan Named Chairman of the Board of Bristol-Myers Squibb
|
|
Sep 05, 01
|
| 08:30 ET |
Dr. Susan Arbuck Joins Bristol-Myers Squibb As Head of Clinical Research for Oncology
|
|
Aug 14, 01
|
| 08:32 ET |
Bristol-Myers Squibb and Sanofi-Synthelabo Submit New Application For Irbesartan in U.S. and Europe for Use Beyond the Treatment of Hypertension
|
|
Aug 10, 01
|
| 09:00 ET |
20 Florida School Districts Now Clean With PRIDE/Microbest
|
|
Aug 09, 01
|
| 19:23 ET |
Bristol-Myers Squibb Statement Regarding Safety of Pravachol(R) (pravastatin sodium)
|
|
Aug 08, 01
|
| 15:30 ET |
Bristol-Myers Squibb Response Statement Regarding The Early Closure Of The Diabetes Prevention Program
|
|
Jul 25, 01
|
| 07:43 ET |
Bristol-Myers Squibb Reports Second Quarter and Six Month Sales & Earnings
|
|
Jul 17, 01
|
| 12:04 ET |
Bristol-Myers Squibb to Announce Second Quarter and Six Month Earnings On Wednesday, July 25, 2001
|
|
Jul 16, 01
|
| 08:53 ET |
Zimmer Management Provides Forecast Guidance; Indicates Zimmer to be listed on NYSE
|
|
Jul 05, 01
|
| 08:33 ET |
Bristol-Myers Squibb to Give Stockholders Special Stock Dividend
|
|
Jun 07, 01
|
| 16:15 ET |
Bristol-Myers Squibb to Acquire Dupont Pharmaceuticals Company for $7.8 Billion
|
|
Jun 05, 01
|
| 16:45 ET |
Bristol-Myers Squibb Company Announces $2 Billion Increase in Its Common Stock Repurchase Program; Declares Common Stock Dividend of $.275
|
|
| 05:20 ET |
New Study Reveals Accountants Top List of Professionals That Suffer the Most Headaches
|
|
May 23, 01
|
| 16:47 ET |
Over 1,000 Cyclists And Spectators To Participate In American Diabetes Association's Tour De Cure At Bristol-Myers Squibb Company
|
|
May 15, 01
|
| 17:04 ET |
Bristol-Myers Says VANLEV Study Continues; OCTAVE Study Data to Remain Blinded
|
|
May 14, 01
|
| 08:19 ET |
OTN, a BMS Subsidiary, and NexCura Announce Multi-Year Agreement
|
|
May 09, 01
|
| 15:50 ET |
The Mother of All Headaches - Tips to Help Mom Manage Her Migraines -
|
|
May 01, 01
|
| 11:05 ET |
Peter R. Dolan Succeeds Charles A. Heimbold, Jr. As Chief Executive Officer of Bristol-Myers Squibb
|
|
Apr 25, 01
|
| 07:42 ET |
Bristol-Myers Squibb Reports Record First Quarter Sales & Earnings
|
|
Apr 12, 01
|
| 15:41 ET |
Bristol-Myers Squibb to Announce its First Quarter Earnings on Wednesday, April 25, 2001
|
|
Apr 02, 01
|
| 16:30 ET |
Bristol-Myers Squibb Strengthens Senior Management Team to Support Growth Strategy
|
|
Mar 28, 01
|
| 11:15 ET |
New Excedrin(R) Brand Tension Headache Cooling Pads Provide Fast, Convenient Relief
|
|
Mar 22, 01
|
| 14:17 ET |
Patients With Type 2 Diabetes and Coronary Artery Disease Have Improved Long-Term Survival if Treated With Metformin
|
|
Mar 19, 01
|
| 10:29 ET |
Follow Up Results From the Landmark Lipid Trial Provide Additional Information About The Long-Term Benefits of Pravastatin Therapy for Women With Heart Disease
|
|
Mar 15, 01
|
| 16:14 ET |
New Study Published in Hypertension Highlights the Importance of Systolic Blood Pressure Control
|
|
Mar 14, 01
|
| 10:03 ET |
Bristol-Myers Squibb Announces Accelerated Program to Fight HIV/AIDS in Africa
|
|
Mar 12, 01
|
| 11:11 ET |
Dr. Elliott Sigal Promoted to Senior Vice President Drug Discovery And Exploratory Development at Bristol-Myers Squibb
|
|
Mar 06, 01
|
| 15:49 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Feb 22, 01
|
| 13:48 ET |
Bristol-Myers Squibb to Spin-Off Zimmer
|
|
Feb 12, 01
|
| 16:45 ET |
Don't Let Your Headache Cause You Heartache - How to Avoid Common Migraine Triggers This Valentine's Day -
|
|
Feb 07, 01
|
| 08:36 ET |
Peter R. Dolan Named Next CEO of Bristol-Myers Squibb
|
|
Feb 06, 01
|
| 16:01 ET |
Bristol-Myers Squibb to Conduct Clinical Studies of Glucovance(R) (Glyburide And Metformin Hydrochloride Tablets) in Children With Type 2 Diabetes
|
|
Jan 24, 01
|
| 07:28 ET |
Bristol-Myers Squibb Reports Fourth Quarter and 2000 Sales & Earnings
|
|
Jan 19, 01
|
| 13:15 ET |
Non-Prescription Migraine Relievers Can Make Life Easier For Sufferers, But Choosing Can Be Difficult
|
|
Jan 18, 01
|
| 15:53 ET |
Bristol-Myers Squibb to Announce Its Fourth Quarter And Year-End Earnings on Wednesday, January 24, 2001.
|
|
| 09:08 ET |
Bristol-Myers Squibb Completes Enrollment in OCTAVE Study for VANLEV(TM)
|
|
Dec 21, 00
|
| 08:04 ET |
Does Your Heartthrob's Head Throb?
|
|
Dec 15, 00
|
| 11:57 ET |
Study Results Show That Pravastatin Therapy Started Immediately After an Acute Coronary Syndrome (ACS) Reduces the Risk of Coronary Events and Slows Progression of Atherosclerosis
|
|
Dec 07, 00
|
| 16:32 ET |
FDA Confirms Bristol-Myers Squibb's BuSpar Patent is Listed in Orange Book
|
|
Dec 05, 00
|
| 16:44 ET |
Bristol-Myers Squibb Company Announces a 12% Increase in Its Common Stock Dividend
|
|
Nov 29, 00
|
| 08:00 ET |
Bristol-Myers Squibb Announces Clinical Development Program for Combretastatin A4 Prodrug
|
|
Nov 28, 00
|
| 12:00 ET |
One Million New U.S. Prescriptions Reached by TEQUIN(R) (gatifloxacin), Bristol-Myers Squibb's Quinolone Antibiotic
|
|
Nov 21, 00
|
| 13:03 ET |
Bristol-Myers Squibb Discovers New Mechanism of Action for Anti-Anxiety Medication
|
|
Nov 15, 00
|
| 11:54 ET |
Clinical Trial to be Initiated With Irbesartan in the Treatment of Heart Failure
|
|
Oct 31, 00
|
| 16:53 ET |
U.S. Food And Drug Administration Approves Bristol-Myers Squibb's New VIDEX(R) EC (didanosine) Delayed Release Capsules
|
|
Oct 24, 00
|
| 13:02 ET |
Bristol-Myers Squibb Announces VANIQA(TM) (eflornithine hydrochloride) Cream, 13.9%, the First Prescription Cream to Help Treat Unwanted Facial Hair, Is Now Available Nationwide
|
|
Oct 19, 00
|
| 07:41 ET |
Bristol-Myers Squibb Reports Third Quarter and Nine Month Sales & Earnings
|
|
Oct 18, 00
|
| 11:13 ET |
Novartis and Bristol-Myers Squibb Announce Strategic Alliance for Zelmac(TM)
|
|
Oct 17, 00
|
| 11:07 ET |
Web Cast and Telephone Call-In Available for Bristol-Myers Squibb Quarterly Earnings Conference Call
|
|
| 10:19 ET |
New Data Confirms That Pravastatin is Effective in Reducing the Rate Of Coronary Heart Disease in a Wide Range of Patients Including Those With Diabetes and High Blood Pressure
|
|
Oct 16, 00
|
| 10:36 ET |
Bristol-Myers Squibb Receives U.S. Food and Drug Administration (FDA) Approval Of Glucophage(R) XR (Metformin HCl Extended Release Tablets) For Type 2 Diabetes
|
|
Sep 28, 00
|
| 09:39 ET |
Bristol-Myers Squibb Announces a 'Strategy for Growth' - Company Sharpens Its Focus On Medicines Business -
|
|
Sep 27, 00
|
| 17:16 ET |
`Diabetes Diner Talk' Radio Program to Target Growing Number of Americans With Type 2 Diabetes
|
|
| 07:00 ET |
Bristol-Myers Squibb and Lexicon Genetics Initiate Genomics Collaboration
|
|
Sep 26, 00
|
| 16:07 ET |
BRISTOL-MYERS SQUIBB TO HOLD INVESTMENT COMMUNITY MEETING SEPTEMBER 28, 2000
|
|
Sep 25, 00
|
| 11:31 ET |
`Diabetes Diner Talk' Kicks Off at Ellen's Stardust Diner in New York City
|
|
Sep 20, 00
|
| 17:06 ET |
Bristol-Myers Squibb Announces $2 Billion Increase In Its Common Stock Repurchase Program
|
|
| 10:37 ET |
Largest Clinical Study Confirms the Safety and Efficacy of TEQUIN(R) (gatifloxacin) in Treating Community Acquired Respiratory Tract Infections
|
|
Sep 15, 00
|
| 15:20 ET |
Bristol-Myers Squibb is Honored for its Diversity Efforts by The Long Island Hispanic Business Community
|
|
Sep 12, 00
|
| 16:05 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Aug 31, 00
|
| 11:32 ET |
Role of Over-the-Counter Migraine Drugs Discussed at National Headache Meeting
|
|
Aug 23, 00
|
| 10:28 ET |
Bristol-Myers Squibb Scientists Named `Heroes of Chemistry'; David Cushman & Miguel Ondetti Honored by American Chemical Society
|
|
Aug 16, 00
|
| 09:35 ET |
Beth C. Seidenberg, M.D., Appointed Senior Vice President, Clinical Development and Life Cycle Management at Bristol-Myers Squibb Company
|
|
Aug 15, 00
|
| 09:06 ET |
Bristol-Myers Squibb Complies with Temporary Restraining Order
|
|
Aug 02, 00
|
| 17:00 ET |
Risk of Stroke Reduced by Cholesterol-Lowering Drug
|
|
| 15:50 ET |
Bristol-Myers Squibb Receives FDA Approval of Glucovance(TM) (Glyburide and Metformin HCL Tablets) for Type 2 Diabetes
|
|
Aug 01, 00
|
| 08:22 ET |
Bristol-Myers Squibb's Quinolone Antibiotic TEQUIN(TM) (gatifloxacin) Passes Half-Million Mark in New U.S. Prescriptions
|
|
Jul 31, 00
|
| 12:12 ET |
Bristol-Myers Squibb and The Gillette Company Announce FDA Approval Of VANIQA(TM)(eflornithine hydrochloride) Cream, 13.9% as Treatment For Women With Unwanted Facial Hair
|
|
Jul 26, 00
|
| 11:07 ET |
Bristol-Myers Squibb Salutes Lance Armstrong Following Astonishing Victory At Tour de France
|
|
Jul 20, 00
|
| 07:24 ET |
Bristol-Myers Squibb Reports Record Second Quarter and Six Month Sales & Earnings
|
|
Jul 17, 00
|
| 12:00 ET |
Bristol-Myers Squibb Announces Large-Scale Clinical Study With Omapatrilat for the Treatment of Hypertension
|
|
Jul 10, 00
|
| 15:53 ET |
TAXOL (paclitaxel) Injection Approved by FDA for Expanded Administration Regimen in the Treatment of Advanced Ovarian Cancer
|
|
Jun 29, 00
|
| 09:30 ET |
Bristol-Myers Squibb Announces Major Sponsorship of the U.S. Postal Service Cycling Team at the Tour de France
|
|
Jun 21, 00
|
| 17:22 ET |
Bristol-Myers Squibb Company to Host the American Diabetes Association's Princeton, NJ Tour de Cure 2000
|
|
Jun 12, 00
|
| 10:41 ET |
New Therapy May Shift Paradigm for Type 2 Diabetes Treatment
|
|
| 10:26 ET |
New Oral Antidiabetic May Change Treatment Paradigm for Patients With Type 2 Diabetes
|
|
| 10:23 ET |
Bristol-Myers Squibb and Exelixis Announce Expansion of Collaboration; Novel Approach to Drug Discovery Through `Chemical Genomics'
|
|
Jun 06, 00
|
| 16:19 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Jun 01, 00
|
| 15:21 ET |
'Milestones in Migraine Management' Introduced During National Headache Awareness Week
|
|
| 11:26 ET |
Because Sun Damage = Skin Damage ...
|
|
May 25, 00
|
| 09:28 ET |
Bristol-Myers Squibb Tops List of Eco-Friendly Companies
|
|
May 22, 00
|
| 18:35 ET |
Bristol-Myers Squibb and Ligand Sign Collaborative Agreement; Targets Hypertension, Congestive Heart Failure
|
|
| 15:51 ET |
FDA Extends BuSpar(R) Exclusivity
|
|
May 16, 00
|
| 12:48 ET |
New Phase III Data on Novel Anti-Psychotic Aripiprazole Presented Today at Psychiatric Conference
|
|
May 11, 00
|
| 06:01 ET |
Bristol-Myers Squibb to Join Public/Private Effort to Accelerate Access To HIV/AIDS Care and Treatment in Developing Countries
|
|
May 03, 00
|
| 09:40 ET |
New Headache Treatment Guidelines Recognize Excedrin(R) Migraine as First-Line Therapy for Mild-to-Severe Migraine
|
|
Apr 20, 00
|
| 11:17 ET |
The Mother of All Headaches - Tips to Help Mom Manage her Migraines -
|
|
| 09:23 ET |
Bristol-Myers Squibb Resubmits UFT(R) New Drug Application to the U.S. FDA
|
|
| 07:55 ET |
Bristol-Myers Squibb Reports Record First Quarter Sales & Earnings
|
|
Apr 19, 00
|
| 13:30 ET |
Bristol-Myers Squibb to Delay U.S. Regulatory Review of VANLEV(TM) Pending Additional Studies
|
|
Apr 07, 00
|
| 12:17 ET |
Court Allows Bristol-Myers Squibb's Appeal
|
|
Mar 20, 00
|
| 14:32 ET |
U.S. Food and Drug Administration Extends Glucophage(R) (Metformin Hydrochloride Tablets) Exclusivity
|
|
Mar 17, 00
|
| 14:00 ET |
Bristol-Myers Squibb Withdraws UFT(R) and ORZEL(TM) Applications From The U.S. FDA; The Company Intends to Resubmit Both Applications
|
|
| 11:56 ET |
Bristol-Myers Squibb Responds to IVAX News Release On Patent Infringement Trial
|
|
Mar 16, 00
|
| 10:40 ET |
FDA Grants Priority Review to Bristol-Myers Squibb's New Once Daily VIDEX(R) (didanosine) Capsules
|
|
Mar 13, 00
|
| 16:08 ET |
Tax Season Stress? Follow this 'E-Z' W-2 Do List to Avoid that Taxing Headache
|
|
| 08:02 ET |
Bristol-Myers Squibb and Schering-Plough Announce U.S. Agreement To Co-Promote TEQUIN(TM) for Respiratory Infections
|
|
Mar 08, 00
|
| 12:13 ET |
Gifted Minority Medical Students to Gather at Bristol-Myers Squibb
|
|
| 09:17 ET |
Bristol-Myers Squibb & Karolinska Institute to Conduct Clinical Trials In Cancer Pharmacogenomics
|
|
Mar 07, 00
|
| 16:03 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Mar 01, 00
|
| 10:56 ET |
Bristol-Myers Squibb Comments on TAXOL(R) Ruling
|
|
Feb 23, 00
|
| 10:33 ET |
Bristol-Myers Squibb Immunology Announces $2 Million Community Leaders Fund AIDS Grant Program; Innovative Hospital-Based AIDS Testing Program Announced As First Recipient
|
|
Feb 15, 00
|
| 09:06 ET |
Bristol-Myers Squibb Says Trial Postponed
|
|
Feb 11, 00
|
| 10:37 ET |
More Than Two Million Patients Worldwide Have Been Prescribed Antiplatelet Drug Plavix(R) (Clopidogrel Bisulfate)
|
|
Feb 08, 00
|
| 12:03 ET |
Bicycle Messengers in Seattle Support Lance Armstrong's New Cancer Education Campaign
|
|
| 12:02 ET |
Bicycle Messengers in New York City Support Lance Armstrong's New Cancer Education Campaign
|
|
| 12:02 ET |
Bicycle Messengers in Philadelphia Support Lance Armstrong's New Cancer Education Campaign
|
|
| 12:01 ET |
Bicycle Messengers in Minneapolis Support Lance Armstrong's New Cancer Education Campaign
|
|
| 12:00 ET |
Bicycle Messengers in Columbus Support Lance Armstrong's New Cancer Education Campaign
|
|
| 12:00 ET |
Bicycle Messengers in the Nation's Capital Support Lance Armstrong's New Cancer Education Campaign
|
|
Jan 31, 00
|
| 11:00 ET |
Tour de France Champion Lance Armstrong Launches The Cycle of Hope Cancer Education Campaign
|
|
Jan 24, 00
|
| 08:10 ET |
Bristol-Myers Squibb Reports Record Fourth Quarter And 1999 Sales & Earnings -- Sales Cross $20 Billion Mark
|
|
Jan 18, 00
|
| 10:01 ET |
Bristol-Myers Squibb Receives FDA Approval for TEQUIN(TM), A New Type of Quinolone Antibiotic
|
|
Jan 13, 00
|
| 06:00 ET |
Bristol-Myers Squibb Introduces Theragran(R) Heart Right(TM)
|
|
Jan 10, 00
|
| 10:41 ET |
FDA Grants Priority Review to VANLEV(TM) (Omapatrilat), Bristol-Myers Squibb's Novel Antihypertensive Drug
|
|
Jan 06, 00
|
| 09:45 ET |
Bristol-Myers Squibb to Seek Buyer for Matrix Essentials Subsidiary
|
|
Dec 21, 99
|
| 10:26 ET |
Bristol-Myers Squibb Announces Approval of TEQUIN (gatifloxacin)
|
|
Dec 20, 99
|
| 15:25 ET |
Bristol-Myers Squibb Seeks Regulatory Approvals Worldwide for Novel Antihypertension Drug VANLEV(TM); New Drug May Prove to Help Millions Of Patients With High Blood Pressure
|
|
Dec 16, 99
|
| 04:27 ET |
Bristol-Myers Squibb and OXiGENE Announce Research and Licensing Agreement For Combretastatin Anti-Tumor Agents
|
|
Dec 08, 99
|
| 08:32 ET |
Bristol-Myers Squibb Announces a 14% Increase in Its Common Stock Dividend and a $2 Billion Increase in Its Common Stock Repurchase Program
|
|
Nov 17, 99
|
| 13:16 ET |
Bristol-Myers Squibb Files New Drug Application for Glucophage(R) XR (Metformin Hydrochloride) Extended Release Tablets
|
|
Nov 11, 99
|
| 08:01 ET |
Bristol-Myers Squibb and Millennium Predictive Medicine Establish Unique Pharmacogenomics Alliance in Cancer Treatment
|
|
| 08:00 ET |
Bristol-Myers Squibb to Pioneer Personalized Medicines for Cancer Patients
|
|
Nov 08, 99
|
| 09:51 ET |
Bristol-Myers Squibb Announces Launch of PROVE IT Trial Comparing Pravachol(R) (Pravastatin Sodium) vs. Lipitor(R) (Atorvastatin Calcium)
|
|
Nov 02, 99
|
| 09:15 ET |
The FDA Approves Once Daily Dosing For VIDEX(R) (didanosine) Tablets
|
|
Oct 19, 99
|
| 07:55 ET |
Bristol-Myers Squibb Reports Record Third Quarter And Nine Months Sales & Earnings
|
|
Oct 15, 99
|
| 15:22 ET |
Bristol-Myers Squibb and Lance Armstrong Join Forces in Cycle of Hope Cancer Campaign
|
|
Oct 08, 99
|
| 09:27 ET |
Excedrin(R) Migraine Becomes First Non-Prescription Medication FDA-Approved for the Full Migraine Syndrome
|
|
Oct 04, 99
|
| 13:40 ET |
Bristol-Myers Squibb Introduces Theragran(R) Heart Right(TM)
|
|
| 09:50 ET |
Bristol-Myers Squibb and The Gillette Company File for Approval for VANIQA(TM)
|
|
Sep 30, 99
|
| 10:06 ET |
Bristol-Myers Squibb Files New Drug Application for Novel Oral Antidiabetic Drug
|
|
Sep 21, 99
|
| 09:02 ET |
Bristol-Myers Squibb and Otsuka Announce Commercialization Agreement For Aripiprazole
|
|
Sep 17, 99
|
| 10:07 ET |
FDA Advisory Committee Recommends Bristol-Myers Squibb's TAXOL(R) (paclitaxel) Injection for Adjuvant Treatment of Breast Cancer; Anti-Cancer Agent Continues to Demonstrate Versatility
|
|
Sep 15, 99
|
| 08:46 ET |
Bristol-Myers Squibb Company and Exelixis Pharmaceuticals Announce Unique Genetic Model Systems Alliance; Collaboration Represents a Novel Approach To Target Validation for New Medicines
|
|
Sep 14, 99
|
| 15:44 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Sep 08, 99
|
| 08:59 ET |
FDA Approves New Indications for ZERIT(R) (stavudine) And VIDEX(R) (didanosine)
|
|
Sep 07, 99
|
| 07:59 ET |
Second Regional Update Conference on African-Americans and AIDS New York, September 14
|
|
Sep 03, 99
|
| 10:21 ET |
Bristol-Myers Squibb and the Government of South Africa Announce Partnership to Address HIV/AIDS
|
|
Aug 20, 99
|
| 05:20 ET |
Expert Consensus: Caffeine Increases Effectiveness of Pain Relievers for Migraine and Other Headaches
|
|
Aug 11, 99
|
| 14:56 ET |
Redmond Products, Inc. to Voluntarily Recall Six Batches of Aussie Land Kangaroo Island Detangler
|
|
Jul 21, 99
|
| 11:35 ET |
Bristol-Myers Squibb Reports Record Second Quarter and Six Month Sales & Earnings
|
|
Jul 08, 99
|
| 11:04 ET |
Bristol-Myers Squibb Launches New Safety Database System
|
|
Jun 25, 99
|
| 09:01 ET |
Study Shows OTC Pain Medication May Help Relieve Debilitating Condition: Menstruation-Associated Migraine
|
|
Jun 22, 99
|
| 10:24 ET |
Bristol-Myers Squibb Files a Supplemental New Drug Application (sNDA) For TAXOL(R)/Herceptin(R) Combination
|
|
Jun 11, 99
|
| 09:28 ET |
Bristol-Myers Squibb Employees Cycle in 1999 Tour De Cure To Raise Funds to Fight Type 2 Diabetes
|
|
Jun 03, 99
|
| 09:57 ET |
Next Generation of Scientific Leaders to Receive Bristol-Myers Squibb Grants; Unrestricted Grants to Support Academic Research in Synthetic Organic Chemistry
|
|
Jun 01, 99
|
| 15:49 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
May 18, 99
|
| 11:38 ET |
Landmark Serzone Chronic Depression Study Offers Great Hope For People Suffering From Depression
|
|
May 13, 99
|
| 13:37 ET |
AVALIDE(R) -- A New Treatment Option for Patients With High Blood Pressure -- Now Available in Pharmacies Nationwide
|
|
Apr 29, 99
|
| 08:50 ET |
Bristol-Myers Squibb Announces Major Advance for TAXOL (Paclitaxel) Injection For the Treatment of Breast Cancer
|
|
Apr 27, 99
|
| 17:37 ET |
President Clinton Presents National Medal of Technology to Bristol-Myers Squibb
|
|
Apr 21, 99
|
| 08:30 ET |
BRISTOL-MYERS SQUIBB REPORTS RECORD FIRST QUARTER SALES & EARNINGS
|
|
Mar 25, 99
|
| 09:17 ET |
First Annual Bristol-Myers Squibb Symposium to Further Interest in Synthetic Organic Chemistry; Unrestricted Grant Recipients and Fellows to Present Research Findings
|
|
Mar 09, 99
|
| 09:39 ET |
Bristol-Myers Squibb Completes Regulatory Filing for ORZEL(TM) For Colon Cancer
|
|
Mar 02, 99
|
| 15:53 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Feb 10, 99
|
| 10:46 ET |
Bristol-Myers Squibb Statement on Lobucavir
|
|
Feb 09, 99
|
| 17:43 ET |
Bristol-Myers Squibb and EntreMed Modify Research Agreement
|
|
Jan 20, 99
|
| 08:38 ET |
Bristol-Myers Squibb Reports Record Fourth Quarter and Annual Sales
|
|
Jan 05, 99
|
| 09:15 ET |
Bristol-Myers Squibb Files for Approval of New Antibiotic; Seeking Marketing Approval for TEQUIN(TM) to Treat Respiratory and Other Infections
|
|
Dec 22, 98
|
| 15:58 ET |
Bristol-Myers Squibb Announces an Exclusive License Agreement With Dura Pharmaceuticals
|
|
Dec 17, 98
|
| 13:00 ET |
Researchers at MIT and Yale to Receive Bristol-Myers Squibb Grants; Unrestricted Grants to Further Interest in Synthetic Organic Chemistry
|
|
Dec 08, 98
|
| 16:04 ET |
Bristol-Myers Squibb Wins National Medal of Technology
|
|
Dec 01, 98
|
| 12:15 ET |
Bristol-Myers Squibb Announces Two-For-One Stock Split And a 10% Increase in its Common Stock Dividend
|
|
Nov 16, 98
|
| 08:47 ET |
Bristol-Myers Squibb Projects End of Implant Litigation
|
|
Nov 10, 98
|
| 10:52 ET |
Bristol-Myers Squibb Announces Management Changes to Help Drive Growth and Enhance Shareholder Value
|
|
Nov 09, 98
|
| 18:47 ET |
Bristol-Myers Squibb Announces Largest Phase III Clinical Trials for Oral Treatment of Hepatitis B Virus and Results From Largest Phase II Trial
|
|
Nov 05, 98
|
| 17:00 ET |
Landmark Heart Study Published in the New England Journal of Medicine, Says the National Heart Foundation of Australia
|
|
Nov 02, 98
|
| 15:35 ET |
Bristol-Myers Squibb Elects Textron Chief to its Board
|
|
Oct 26, 98
|
| 14:59 ET |
Bristol-Myers Squibb to Acquire Korean Pharmaceutical Company
|
|
Oct 22, 98
|
| 08:04 ET |
To Boldly Go - Bristol-Myers Squibb In Space; From Ocean Floor to Outer Space, Scientists Search for New Medicines
|
|
Oct 19, 98
|
| 11:13 ET |
Albuquerque Jury Uses Science Data to Reject Plaintiff's Claims In Breast Implant Case
|
|
| 10:58 ET |
Bristol-Myers Squibb Acquires New Des-Fluoroquinolone Drug From Toyama
|
|
| 08:44 ET |
Bristol-Myers Squibb Reports Record Third Quarter and Nine Month Sales and Earnings
|
|
Oct 07, 98
|
| 15:48 ET |
Zimmer Sponsors Mercury Awards for Hospital Excellence; Partnership Provides Consumers Objective Rankings of Hospitals
|
|
| 11:20 ET |
Bristol-Myers Squibb Opens Advanced Research Facility Expansion Houses High-Speed Robotics for Drug Discovery
|
|
Oct 06, 98
|
| 09:14 ET |
Bristol-Myers Squibb Licenses Hair Research From Unilever
|
|
Oct 01, 98
|
| 10:57 ET |
Bristol-Myers Squibb Elects Volvo Chief as New Board Member
|
|
Sep 24, 98
|
| 17:57 ET |
Bristol-Myers Squibb Foundation Pledges $100,000 for Puerto Rico Relief
|
|
Sep 21, 98
|
| 14:59 ET |
Bristol-Myers Squibb to Divest Three Consumer Brands
|
|
Sep 14, 98
|
| 17:00 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Sep 10, 98
|
| 07:30 ET |
Bristol-Myers Squibb and Molecumetics Sign Immunology and Inflammmation Research Alliance
|
|
Jul 28, 98
|
| 12:15 ET |
Trial Results Show Significant Reduction in Risk of Recurrent Cardiovascular Events with Pravachol(R) (Pravastatin Sodium) in Women with Normal Cholesterol
|
|
Jul 21, 98
|
| 08:17 ET |
Bristol-Myers Squibb Reports Record Second Quarter and Six Month Sales and Earnings
|
|
Jun 19, 98
|
| 09:14 ET |
Bristol-Myers Squibb Response Statement Regarding the Release of AHA Stroke Survey Results
|
|
Jun 15, 98
|
| 09:14 ET |
Bristol-Myers Squibb And Medarex Announce HuMAb-Mouse(TM) Collaboration
|
|
Jun 10, 98
|
| 13:04 ET |
Statement Addressing Senator Boxer's Breast Implant Research Bill
|
|
Jun 09, 98
|
| 12:15 ET |
FDA Clears New Labeling for Pravachol(R) (Pravastatin Sodium) Which Highlights Reduced Potential for Drug Interactions
|
|
Jun 08, 98
|
| 10:36 ET |
Bristol-Myers Squibb Company Announces Dividend
|
|
Jun 04, 98
|
| 12:59 ET |
Bristol-Myers Squibb & Phyton Agree to Commercialize Innovative Technology for Production of TAXOL(R)
|
|
| 09:31 ET |
Bristol-Myers Squibb & Phyton Agree to Commercialize Innovative Technology For Production of TAXOL(R)
|
|
Jun 03, 98
|
| 09:13 ET |
Bristol-Myers Squibb and IRORI Announce Combinatorial Chemistry Collaboration; BMS Makes $4.5 Million Equity Investment in IRORI
|
|
May 15, 98
|
| 10:27 ET |
SENTRY ANTIMICROBIAL SURVEILLANCE Reports Regional Resistance Patterns, Reinforces Need For Global Surveillance
|
|
May 05, 98
|
| 00:00 ET |
Bristol-Myers Squibb Board of Directors Authorizes Additional $2 Billion Increase in Its Common Stock Repurchase Program
|
|
| 00:00 ET |
Recent Study Shows Close to Half of All Migraine Sufferers May Not Realize They Have Migraines
|
|
Apr 23, 98
|
| 12:25 ET |
Bristol-Myers Squibb Taxol(R) Data Exclusivity in Europe Upheld by Dutch Court
|
|
Apr 21, 98
|
| 12:14 ET |
Bristol-Myers Squibb Reports Record First Quarter Sales and Earnings
|
|
Apr 20, 98
|
| 11:51 ET |
New Evidence From Landmark Pravachol(R) (pravastatin sodium) Trials Demonstrates Significant Heart Attack Prevention Without Reducing Cholesterol to Very Low Levels
|
|
Apr 09, 98
|
| 09:49 ET |
Bristol-Myers Squibb Licenses Cancer Research To Seattle Genetics
|
|
Apr 08, 98
|
| 11:08 ET |
Survey Shows Majority of Americans Over Age 45 Don't Know Their Blood Sugar Levels -- A Key Indicator for Type 2 Diabetes
|
|
Apr 07, 98
|
| 12:40 ET |
Bristol-Myers Squibb to Launch `Learn Your Level' Type 2 Diabetes Awareness Initiative Targeting Estimated Five Million Americans Still Undiagnosed
|
|
Apr 03, 98
|
| 09:53 ET |
Bristol-Myers Squibb and Acacia Biosciences Enter Agreement for Compound Profiling
|
|
Apr 01, 98
|
| 15:29 ET |
Results of LIPID Study Which Demonstrate Benefits of Pravachol in Reducing Risk of Stroke Presented at the American College of Cardiology Annual Meeting
|
|
Mar 30, 98
|
| 17:35 ET |
Research Fellowships in Autism Announced; Bristol-Myers Squibb Foundation to Fund Autism Research
|
|
| 17:32 ET |
Audio Teleconference Press Briefing: FDA Clears New Indication For Bristol-Myers Squibb's Pravachol(R) -- A Major Advance In the Prevention of Stroke
|
|
Mar 27, 98
|
| 17:31 ET |
FDA Clears New Indication for Bristol-Myers Squibb's Pravachol(R) -- a Major Advance in the Prevention of Stroke
|
|
Mar 20, 98
|
| 12:36 ET |
Oncologic Drugs Advisory Committee Recommends TAXOL(R) for First-Line Use in Advanced Ovarian Cancer
|
|
Mar 17, 98
|
| 13:02 ET |
Bristol-Myers Squibb Enters Into $500 Million Competitive Advance and Revolving Credit Facilities
|
|
Mar 13, 98
|
| 09:57 ET |
Bristol-Myers Squibb Supports Type 2 Diabetes Awareness Initiative As Part of Expo for Today's Black Woman
|
|
| 09:36 ET |
Bristol-Myers Squibb Joins With American Diabetes Association In Launching Operation Detect Diabetes
|
|
Mar 05, 98
|
| 10:24 ET |
Bristol-Myers Squibb & UT Austin in Cancer Collaboration; Scientists Develop Novel Anticancer Therapies
|
|
Mar 03, 98
|
| 16:16 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Feb 11, 98
|
| 09:14 ET |
Bristol-Myers Squibb & Chiroscience In Cancer Collaboration; BMS Licenses Two Innovative New Cancer Drugs
|
|
Feb 09, 98
|
| 09:18 ET |
Unrestricted Chemistry Grants & Fellowships Announced; Bristol-Myers Squibb To Fund Synthetic Organic Chemistry Research
|
|
Feb 03, 98
|
| 08:55 ET |
CARE Study Results Provide Important News for Patients
|
|
Jan 28, 98
|
| 09:18 ET |
Zerit Usage Outpaces AZT; Efficacy, Resistance Profile and Convenience Cited
|
|
Jan 22, 98
|
| 13:08 ET |
First Call Corrects Bristol-Myers Squibb Earnings Report
|
|
| 08:00 ET |
Bristol-Myers Squibb Reports Record Fourth Quarter And Annual Sales and Earnings
|
|
Jan 14, 98
|
| 11:25 ET |
FDA Clears Excedrin(R) Migraine for Migraine Headache Pain - First and Only Migraine Medication Available Without Prescription -
|
|
Dec 23, 97
|
| 10:06 ET |
Bristol-Myers Squibb to Acquire Redmond Products, Major U.S. Hair Care Products Company
|
|
Dec 18, 97
|
| 20:07 ET |
Bristol-Myers Squibb Statement Regarding FDA Announcement About Posicor
|
|
Dec 17, 97
|
| 11:57 ET |
Bristol-Myers Squibb Elects New Board Member
|
|
| 09:31 ET |
Bristol-Myers Squibb Elects New Board Member
|
|
Dec 05, 97
|
| 09:30 ET |
Bristol-Myers Squibb Seeks to Double New Product Launches; BMS Outlines Ambitious R&D Goals at Meeting for Wall Street Analysts
|
|
Dec 04, 97
|
| 10:49 ET |
Explanation of Revenue Recognition for Avapro & Plavix
|
|
Dec 02, 97
|
| 15:26 ET |
Bristol-Myers Squibb Increases Dividend
|
|
| 09:26 ET |
Bristol-Myers Squibb and Pharmacopeia Form Research Alliance In Immunology/Inflammation
|
|
Dec 01, 97
|
| 08:54 ET |
Bristol-Myers Squibb and Arris Pharmaceutical to Develop Hepatitis C Inhibitors
|
|
Nov 18, 97
|
| 08:43 ET |
Sanofi and Bristol-Myers Squibb Receive Clearance to Market PLAVIX(R)
|
|
Nov 17, 97
|
| 09:45 ET |
Bristol-Myers Squibb Appoints Applied Genomics Leader; Elliott Sigal to Head New Department Exploring Genetic Links to Disease
|
|
Nov 13, 97
|
| 10:44 ET |
Bristol-Myers Squibb to Seek Buyer for GEA Farmaceutisk Fabrik
|
|
Nov 12, 97
|
| 18:28 ET |
Bristol-Myers Squibb Statement Regarding the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study
|
|
| 08:35 ET |
Landmark Heart Study Makes Medical History
|
|
Nov 10, 97
|
| 19:30 ET |
Bristol-Myers Squibb Statement Regarding 'The Relationship Between LDL-C Changes and Coronary Heart Disease Event Reduction in the West of Scotland Coronary Prevention Study (WOSCOPS)'
|
|
| 11:17 ET |
Lay Home Educators Help Meet the Challenge of a Changing American Health Care System
|
|
Oct 21, 97
|
| 08:27 ET |
Bristol-Myers Squibb Reports Record Third Quarter Sales And Earnings
|
|
Oct 16, 97
|
| 10:02 ET |
Bristol-Myers Squibb and N.J. Governor Whitman Dedicate Hopewell Research and Administrative Center
|
|
Oct 09, 97
|
| 11:07 ET |
Bristol-Myers Squibb and Karo Bio Enter Collaboration; Partnership to Develop New Treatments for Obesity and High Cholesterol
|
|
Oct 07, 97
|
| 09:17 ET |
Bristol-Myers Squibb and Sanofi Announce New Treatment Option for Patients With High Blood Pressure
|
|
Sep 30, 97
|
| 09:12 ET |
Bristol-Myers Squibb and ICAgen Initiate Ion Channel Collaboration; Alliance to Focus on Small Molecules for Atrial Fibrillation
|
|
| 08:43 ET |
Bristol-Myers Squibb Strengthens Commitment to Hepatitis Research
|
|
Sep 23, 97
|
| 11:56 ET |
New Public Awareness Program Sponsored by Bristol-Myers Squibb Urges Patients With Type 2 Diabetes to Take Charge of Their Disease
|
|
Sep 16, 97
|
| 08:25 ET |
Bristol-Myers Squibb Licenses Genome Therapeutics' Database; DNA Sequence Database May Help Discover New Drugs Against Infectious Disease
|
|
Sep 09, 97
|
| 15:49 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Aug 25, 97
|
| 19:00 ET |
Zerit(R) (stavudine) Approved For First-Line Treatment of HIV in Europe; Indication Includes Adults and Children
|
|
Aug 14, 97
|
| 12:27 ET |
Breast Implant Verdict in Houston Propels Trend Toward Defense; Reliable Science Replaces Pseudo Science
|
|
Aug 07, 97
|
| 15:22 ET |
Bristol-Myers Squibb Offers $300 Million in 100 Year Debentures
|
|
Aug 06, 97
|
| 16:37 ET |
Bristol-Myers Squibb Wins Verdict In California Breast Implant Case
|
|
| 09:23 ET |
Bristol-Myers Squibb Acquires New Anticancer Compounds; Two New Chemotherapeutic Agents Licensed from Taiho Pharmaceutical
|
|
Aug 05, 97
|
| 14:16 ET |
FDA Clears TAXOL for AIDS-Related Kaposi's Sarcoma
|
|
Aug 01, 97
|
| 16:45 ET |
Bristol-Myers Squibb Issues Statement About Taxane Market in the Netherlands
|
|
Jul 22, 97
|
| 08:21 ET |
Bristol-Myers Squibb Reports Record Second Quarter Sales And Earnings
|
|
Jul 21, 97
|
| 09:43 ET |
Bristol-Myers Squibb and German Biotech GBF Developing New Class Of Microbial Anticancer Compounds
|
|
Jul 17, 97
|
| 01:32 ET |
Bristol-Myers Squibb's Taxol(R) Receives Marketing Authorization In Japan For Advanced Ovarian Cancer
|
|
Jul 16, 97
|
| 12:46 ET |
Bristol-Myers Squibb To Sell Its Arthroscopy And Surgical Instruments Businesses
|
|
| 09:20 ET |
Bristol-Myers Squibb and Progenics Pharmaceuticals Announce Licensing Agreement for Cancer Vaccines
|
|
Jul 15, 97
|
| 17:16 ET |
FDA Advisory Panel Recommends Approval of Excedrin(R) For Relief Of Migraine Headache Pain
|
|
Jun 25, 97
|
| 09:11 ET |
Bristol-Myers Squibb to Expand Research Operations
|
|
Jun 24, 97
|
| 10:54 ET |
Bristol-Myers Squibb Issued Patent
|
|
Jun 23, 97
|
| 16:58 ET |
Oncology Drugs Advisory Committee Recommends TAXOL(R) for Kaposi's Sarcoma
|
|
| 12:20 ET |
Bristol-Myers Squibb Statement Regarding Announcement of American Diabetes Association New Recommendations for Diagnosis of Type 2 Diabetes
|
|
Jun 03, 97
|
| 07:30 ET |
Bristol-Myers Squibb Acquires New HIV Protease Inhibitors from Novartis
|
|
Jun 02, 97
|
| 15:51 ET |
Bristol-Myers Squibb Announces Dividend
|
|
| 15:50 ET |
Bristol-Myers Squibb Announces New Board Member
|
|
May 23, 97
|
| 08:43 ET |
Bristol-Myers Squibb Establishes Local Clinical Research & Development Effort in Czech Republic
|
|
May 22, 97
|
| 09:09 ET |
Pierre Le Sourd , M.D., to be Named President of UPSA Laboratories
|
|
May 20, 97
|
| 13:45 ET |
Lung Cancer Trial Demonstrates Advantages of Combination Therapy with TAXOL(R); EORTC Results Corroborate New Standard of Care in Advanced Disease
|
|
May 19, 97
|
| 19:35 ET |
Preliminary Results of Cancer Clinical Trial Show Combination Chemotherapy As An Effective First-Line Therapy for Metastatic Breast Cancer
|
|
May 18, 97
|
| 16:00 ET |
Studies Find Serzone Superior to Prozac in the Treatment of Sleep Disturbance In Depressed Patients
|
|
May 14, 97
|
| 09:52 ET |
Bristol-Myers Squibb Enters Into New R&D Agreement; Anticancer Research Focus of Alliance with Research Triangle Institute
|
|
May 12, 97
|
| 09:43 ET |
Bristol-Myers Squibb Company Announces Nationwide Availability of VAGISTAT-1; First One-Dose OTC Vaginal Yeast Infection Treatment
|
|
May 07, 97
|
| 12:00 ET |
Bristol-Myers Squibb to Acquire Leading Mexican Nutritional Product; Choco Milk(TM) is Country's Biggest Milk-Based Nutritional Supplement
|
|
May 05, 97
|
| 08:20 ET |
Bristol-Myers and Sanofi File in the U.S. and Europe For Approval of New Antithrombotic Drug
|
|
Apr 29, 97
|
| 08:10 ET |
Consortium to Fund Functional Genomics Group at Whitehead/MIT Center For Genome Research
|
|
| 08:09 ET |
Bristol-Myers Squibb Expands Genomics Capabilities
|
|
Apr 22, 97
|
| 08:06 ET |
Bristol-Myers Squibb Reports Record First Quarter Sales And Earnings
|
|
Apr 18, 97
|
| 14:16 ET |
Ian Stuart Named President, Mead Johnson Nutritionals
|
|
Apr 10, 97
|
| 11:41 ET |
Bristol-Myers Squibb Foundation Awards $800,000 to U.S. and Brazilian Medical Institutions for Innovative Women's Community Health Programs
|
|
Mar 21, 97
|
| 11:02 ET |
Leaders in Type II Diabetes Research Present Latest Findings Pertaining to Treatment and Diagnosis
|
|
| 10:23 ET |
Leaders in Type II Diabetes Research Present Latest Findings Pertaining to Treatment and Diagnosis
|
|
Mar 12, 97
|
| 10:44 ET |
First International Mental Health Awareness Organization Meets in Italy
|
|
Mar 11, 97
|
| 09:04 ET |
International Advocacy Association Network is Launched To Unite Worldwide Mental Illness Groups
|
|
Mar 10, 97
|
| 09:04 ET |
Depression Dialogues to Explore the Most Current Issues In the Treatment Of Depression
|
|
Mar 05, 97
|
| 12:05 ET |
Bristol-Myers Squibb Minority Medical Fellows To Present Research at Symposium; 12th Annual Fellowship Program in Academic Medicine for Minority Students
|
|
Mar 04, 97
|
| 15:55 ET |
Bristol-Myers Squibb Announces Dividend
|
|
Mar 03, 97
|
| 08:15 ET |
Bristol-Myers Squibb and Incyte Sign Licensing Agreement for Genomic Database
|
|
Jan 30, 97
|
| 13:26 ET |
Bristol-Myers Squibb Statement Regarding FDA Clearance of Troglitazone For Marketing
|
|
Jan 27, 97
|
| 09:01 ET |
Plans for First Three-Year Black-Beautician Clinical Study Program Announced at U.S. Public Health Meeting
|
|
| 08:00 ET |
Plans for First Three-Year Black-Beautician Clinical Study Program Announced in Washington, D.C., at U.S. Public Health Meeting
|
|
| 02:30 ET |
Bristol-Myers Squibb & Xenova Collaborate on Drug Discovery; Xenova's Natural Product Library Will Enhance BMS's Drug Screening Capability
|
|
Jan 24, 97
|
| 11:10 ET |
Plans For First Three-Year Black-Beautician Clinical Study Program Announced At U.S. Public Health Meeting
|
|
Jan 23, 97
|
| 14:30 ET |
Plans for First Three-Year Black-Beautician Clinical Study Program Announced in Washington, D.C., at U.S. Public Health Meeting
|
|
Jan 22, 97
|
| 08:13 ET |
Bristol-Myers Squibb Reports Record Fourth Quarter and Annual Sales and Earnings
|
|
Jan 17, 97
|
| 18:41 ET |
Bristol-Myers Squibb Announces Voluntary Limited Recall of Ovcon(R) 35
|
|
| 16:33 ET |
Bristol-Myers Squibb Announces Voluntary Limited Recall of Ovcon(R) 35; Mispackaged Oral Contraceptive Poses No Significant Health Threat
|
|
Jan 16, 97
|
| 09:56 ET |
Zerit(R) - An Important New Option For Treating HIV-Infected Children - Now Available
|
|
| 08:26 ET |
Bristol-Myers Squibb Company Announces Novel Chronic Depression Treatment Study
|
|
Jan 07, 97
|
| 15:44 ET |
Bristol-Myers Squibb and Cadus Extend Research Collaboration; BMS Has Confirmed `Hits' With Cadus Drug Discovery Screens
|
|
Dec 18, 96
|
| 15:26 ET |
Bristol-Myers Squibb Statement Regarding FDA Clearance Of Atorvastatin For Marketing
|
|
Dec 12, 96
|
| 08:50 ET |
Bristol-Myers Squibb Acquires Novel Antifungal From Eisai
|
|
Dec 09, 96
|
| 10:56 ET |
Bristol-Myers Squibb and Cubist Pharmaceuticals Announce First Milestone Payment in Potential $56 Million Collaboration For Anti-Infective Drugs
|
|
Dec 05, 96
|
| 09:01 ET |
Bristol-Myers Squibb Company Announces First Multi-Center Study On Hard-To-Treat Acute Otitis Media
|
|
Dec 03, 96
|
| 15:51 ET |
Bristol-Myers Squibb Announces Two-For-One Stock Split And Declares Increased Common Stock Dividend
|
|
| 10:07 ET |
Bristol-Myers Squibb Announces Agreements with The National Institutes of Health
|
|
Dec 02, 96
|
| 08:40 ET |
Bristol-Myers Squibb and Aurora Announce A Research Agreement For Drug Screening Technology
|
|
Nov 12, 96
|
| 14:48 ET |
Bristol-Myers Squibb Offers $350 Million In Debentures
|
|
Nov 11, 96
|
| 11:56 ET |
Women With Heart Disease Can Reduce Their Risk of Recurrent Heart Attack With the Cholesterol-Lowering Drug Pravastatin
|
|
Oct 24, 96
|
| 09:09 ET |
Bristol-Myers Squibb's Cefzil(R) Approved To Treat Acute Bacterial Sinusitis In Adults, Children
|
|
| 08:47 ET |
Bristol-Myers Squibb Establishes Local Clinical Research And Development Effort In Hungary
|
|
Oct 22, 96
|
| 08:13 ET |
Bristol-Myers Squibb Reports Record Third Quarter Sales And Earnings
|
|
Oct 15, 96
|
| 08:03 ET |
Bristol-Myers Squibb Acquires Novel Fluoroquinolone From Kyorin
|
|
Oct 10, 96
|
| 11:30 ET |
Bristol-Myers Squibb Company Finalizes Ad Agency Consolidations
|
|
Oct 02, 96
|
| 17:52 ET |
Pravachol Reduces Risk of Recurrent Heart Attack and Death From Heart Disease According to Study Published in Latest Issue of the New England Journal of Medicine
|
|
Sep 25, 96
|
| 10:15 ET |
Bristol-Myers Squibb Responds to Sankyo/Warner-Lambert Joint Venture Announcement
|
|
Sep 10, 96
|
| 18:19 ET |
Bristol-Myers Squibb Announces Dividend
|
|
| 09:02 ET |
Bristol-Myers Squibb Acquires Beraprost For Claudication From Hoechst Marion Roussel
|
|
Sep 09, 96
|
| 08:05 ET |
Bristol-Myers Squibb Launches Public Awareness Program To Help Prevent First Heart Attack
|
|
Sep 05, 96
|
| 10:05 ET |
Bristol-Myers Squibb Acquires Novel Oncology Drug From Manitoba Cancer Treatment & Research Foundation
|
|
Sep 04, 96
|
| 14:23 ET |
Bristol-Myers Squibb Announces Plans To Expand Worldwide Sales Force
|
|
Aug 20, 96
|
| 08:51 ET |
Bristol-Myers Squibb and Sano Corporation Enter Alliance to Commercialize Transdermal BuSpar(R)
|
|
Aug 14, 96
|
| 12:57 ET |
Bristol-Myers Squibb to Seek Buyer for Its Infection Control and Contamination Control Businesses
|
|
Aug 05, 96
|
| 10:28 ET |
Bristol-Myers Squibb to Acquire Oncology Therapeutics Network; Leading U.S. Distributor of Products and Services to Office-Based Oncologists
|
|
Jul 22, 96
|
| 11:32 ET |
BRISTOL-MYERS SQUIBB REPORTS RECORD SECOND QUARTER SALES AND EARNINGS
|
|